Автореферат и диссертация по медицине (14.00.09) на тему:Эффективность ингаляционных глюкокортикоидов в терапии бронхиальной астмы у детей

Введение

Глава I.

Глава П.

Глава Ш.

Глава IV.

Глава V.

Выводы

1. Абдусаламов А.Б., Шафер А.М. Эффективность мембраностабилизирующей терапии при бронхиальной астме//Тер. арх. -1997. -№3. -С. 32-37.

2. Авдеева О.Е., Лебедин Ю.С., Авдеев С.Н. Гликозилированный муцин-антиген 3EGS сывороточный маркер активности и тяжести при интерстициальных заболеваниях легких//Пульмонология. -1998. -№2. -С. 22-27.

3. Адо В.А, Мокроносова М.А., Перламутров Ю.Н. Аллергия и лейкотриены//Клин. мед. -1995. -Т. 73. -№2. -С. 9-12.

4. Айсанов З.Р., Стулова О.Ю., Колмакова Е.Н. и др. Оценка эффективности комбинированной терапии фликсотидом и серевентом у больных бронхиальной астмой/ЯТульмонология. -1998. -№3. -С. 14-18.

5. Алиев А.М. Иоффе Л.Ц., Дашиев В.А. Диагностическая и оперативная торакоскопия, -Алма-Ата: Медицина. 1988. 34 с.

6. Балаболкин ИИ. Бронхиальная астма//Аллергические болезни у детей: Руководство для врачей/Под ред. Студеникина М.Я., Балаболкина И.И., М.: Медицина, 1998. -188-213 с.

7. Балаболкин И.И. Современные проблемы детской аллергологии/ЯТедиатрия. -1997. -№2. -С. 5-8.

8. Баранова И.А., Гаджиев К.З., Чучалин А.С. Остеопороз у больных бронхиальной астмой//Пульмонология. -1999. -№3. -С. 6-13.

9. Бармина Г.В. Морфология первичного хронического бронхита: гистохимическое, электронно-микроскопическое и морфомегрическое исследование слизистой оболочки: Автореф.дис. канд. мед. наук. -М., 1991. 9 с.

10. Бейлина В.Б., Шевелев В.И., Андросов В.В. Роль супрессии фагоцитарных лейкоцитов респираторного тракта в патогенезе хронического бронхита//Пульмонология. -1992. -№2. -С. 49-52.

11. Беклемишев Н.Д Лейкотриены//Иммунология. -1986. -№5. -С. 11-17.

12. Белоусов Ю.В., Лукьянов С.В., Середа Е.В. и др. Пуриновые и глюкокортикоидные рецепторы у детей с бронхиальной астмой и хроническими бронхолегочными заболеваниями, сопровождающимися бронхообструктивным синдромом//Пульмонология. -1999. -№2. -С. 30-35.

13. Болошина Н.А. Черняк А.В., Пашкова Т.А. и др. Эффект будесонида на позднюю астматическую реакцию и повышение бронхиальной гиперреактивности после аллергенной провокации//Пульмонология. -1999. -№1. -С. 50-53.

14. Бронхиальная астма. Глобальная стратегия. Совместный доклад Национального института Сердце, Легкие, Кровь и ВОЗ//Пульмонология. -1996. -Приложение. -С. 1165.

15. Бронхиальная астма. Руководство для врачей России (Формулярная система)//Пульмонология. -1999. -Приложение. -С. 5-15.

16. Бронхиальная астма/Под ред. Чучалина А.Г. -М: Агар, 1997. -Т. 1. -12 с.

17. Вишневский А.А., Яковлев В.М., Тулеев И.Р. и др.//Педиатрия. -2000. -№2. -С. 911.

18. Вознесенский Н.А., Чучалин А.Г., Антонов Н.С. Окись азота и легкие//Пульмонология. -1998. -№2. -С. 6-10.

19. Гайдашез Э.А., Новиков В.Н., Верхоланцев Ю.А. Клинико-диагностическое значение комплексного исследования бронхоальвеолярной лаважной жидкости при неспецифических воспалительных заболеваниях легких у детей//Педиатрия. -1992. -№1. -С. 64-68.

20. Геппе Н.А. Карпушкина А.В., Большакова Т.Д. и др. Эффективность ингаляционных кортикостероидных препаратов при бронхиальной астме у детей//Росс. вестн. перинат. и педиатрии,- 1997. -Т. 42. №4. -С. 39-43.

21. Гиннатуллин Р.У., Жаков Я.И., Федоров И.А. Морфологические аспекты патогенеза атопической бронхиальной астмы тяжелого течения у детей//Педиатрия. -1997. -№5. -С. 4-8.

22. Глюэр .С.С. (Gluer С.С.) Роль количественной ультразвуковой денситометрии в диагностике остеопороза/Юстеопороз и остеопатиии. -1999. -№3. С. 33-39.

23. Горелова Ж.Ю., Ладодо К.С., Левачев М.М., Лупинович В.Л. и др. Роль полиненасыщенных жирных кислот в лечебном питании детей с аллергическими заболеваниями//Вопросы питания. -1999. -Том 68. -№1. -С. 31-35.

24. Горячкина Л. А., Терехова Е.П., Арутюнов Т.Г. и др. Сравнительная эффективность монотерапии сальметеролом, флютиказон пропионатом и их комбинацией при атопической бронхиальной астме//Пульмонология. -1999. -№3. -С. 65-70.

25. Григоренко А.А., Макаров И.Ю. Корреляционный анализ морфофункционального состояния семенников и бронхов у больных бронхиальной астмой//5 Нац. конгр. по б-ням орг. дых. -М. -1995. -№1473.

26. Гущин И.С. Аллергическое воспаление и его фармакологический контроль. -М.: Фармарус принт, 1998. -69 с.

27. Двойрин В.В., Клименков А.А. Методика контролируемых клинических испытаний. -М.: Медицина, 1985. -23 с.

28. Драпкина О.М., Задорожная О.О., Ивашкин В.Т. и др. Особенности синтеза оксида азота у больных инфарктом миокарда//Клин. мед. -2000.-№3. -С. 19-23.

29. Дрожжев М.Е., Каганов С.Ю. Гормонозависимая бронхиальная астма у детей: клинические особенности и лечение//Росс. вестн. перинат. и педиатриии. -1995. -Т. 40. -№6. -С. 31-37.

30. Емельянов А.В., Шевелев С.Э., Амосов В.И. и др. Эффективность и безопасность ингаляционных глюкокортикоидов у больных бронхиальной астмой/ЛТульмонология. -1999. -№1. -С. 39-42.

31. Емельянов А.В. Трофимов В.И. Влияние гдюкокортикоидной терапии на показатели минерального обмена у больных бронхиальной астмой//Клин. мед. -1995. -Т. 73. -№2. -С. 23-25.

32. Ермаков В.Е., Соколов А.С., Корчагин В.П. и др. Фармакоэкономическая эффективность применения отечественных противоастматических средств/ЛТульмонология. -1997. -№3. -С. 65-70.

33. Жмуров В.А. Лапик С.В., Попова Т.В. Состояние окислительного метаболизма и антиокситантной защитной системы в альвеолярных макрофагах у больных бронхиальной астмой/ЛТульмонология. -1995. -№4. -С. 60-63.

34. Идиопатический фиброзирующий альвеолит, Москва, ноябрь 1998 г.: Конференция в НИИ пульмонологии МЗ РФ/ЛТульмонология. -1999. -№1. -С. 10-23.

35. Кахановский И.М., Соломатин А.С. Беклометазона дипропионат, будесонид и флунизолид в лечении бронхиальной астмы (обзор литературы и собственные исследования)//Тер. арх. -1995. -Т.67. -№3. -С. 34-38.

36. Кахновский Л.А. Маринин В.Ф., Архипова С.В., Сорокина Л.А. Роль и место альдецина в лечении бронхиальной астмы/ЛТульмонология. -1998. -№1. -С. 88-90.

37. Кахновский И.М., Маринин В.Ф., Архипова С.В. и др. Комплексная оценка эффективности ингакорта при лечении больных бронхиальной астмой//Тер. арх. -1998. -Т. 70. -№9. -С. 73-76.

38. Кахновский И.М., Маринин В.Ф., Архипова С.В. и др. Комплексная оценка эффективности альдецина при лечении больных бронхиальной астмой//Тер. арх.1998. -Т. 70. -№3. -С. 22-25.

39. Климанская Е.В. Бронхоскопия при бронхиальной астме у детей//Дет. доктор.1999. -№2. -С. 27-29.

40. Климанская Е.В., Кодолова И.М., Сосюра В.Х. Тюрин Н.А. Клинико-морфологические сопоставления при бронхиальной астме и хронической неспецифической пневмонии у детей//Педиатрия. -1974. -№7. -С. 12-16.

41. Коган А.Х., Даниляк И.Г., Стремоухова А.А. Реакция генерации активных форм кислорода лейкоцитами на гисгамин при различных формах тяжести обострения бронхиальной астмы//Пульмонология. -1995. -№1. -С. 30-34.

42. Кокосов А.Н., Гольденберг Ю.М. Мищенко В.П. Перекисное окисление липидов и гемостаз на этапах формирования хронического бронхита и бронхиальной астмы//Пульмонология. -1995. -№2. -С. 38-43.

43. Коровина О.В. Собченко С.А. Международные мед. обзоры. -1993. -№2. -С. 120123.

44. Ксензова Л.Д. Биосинтез эйкозаноидов гранулоцитами периферической крови у детей с атопическими заболеваниями: Дис.канд. мед. наук. -М., 1997. 134-135 с.

45. Кудрявцева А.В., Балаболкин И.И., Кучеренко А.Г и др. Опыт лечения бронхиальной астмы тяжелого течения у детей с применением ингаляционных глюкокортикостероидов//Педиатрия. -1997. -№2. -С. 102-104.

46. Куммер Ф. Дифференциальная диагностика бронхиальной астмы и хронических обструктивных заболеваний легких. Современные рекомендации по лечению бронхиальной астмы и хронических обструктивных заболеваний легких//Тер. арх. -1995.-Т. 67. -№12. -С. 66-71.

47. Лайт Р.У. Болезни плевры, -М.: Медицина. 1986, 73 с.

48. Леонова В.Г. Анализ эритроцитарных популяций в онтогенезе человека, -Новосибирск: Наука, 1997. 105-108 с.

49. Лещенко И.В., Кузнецова Е.И. Результаты длительного лечения ингакортом больных бронхиальной астмой//Тер. арх. -1997. -Т. 69. -№12. -С. 52-54.

50. Лизенко М.В., Петровский В.И., Бахирев А.М. Корригирующее влияние гдюкокортикоидов, разгрузочно-физической терапии на липидный статус эритроцитов больных бронхиальной астмой//Пульмонология. -1999. -№1. -С. 24-28.

51. Лизенко М.В., Петровский В.И., Котенко Т.В. Изменение липидного состава липопротеидов сыворотки крови в процессе лечения гормонами больных бронхиальной астмой//Тер. арх. -1995. -Том 67. -№11. -С. 35-38.

52. Линдрус X. Применение высоких доз кортикостероидов в виде ингаляций при лечении астмы/УПульмонология. -1991. -№2. -С. 38-40.

53. Лукомский Г.И., Шулутко М.Л., Виннер М. Г., Смешнев А.С. Бронхология, -М.: Медицина, 1973. -76 с.

54. Лукомский Г.И., Шулутко М.Л., Виннер М.Г. и др. Бронхопульмонология, -М.: Медицина, 1982. 64 с.

55. Лукьянчиков B.C., Калинин А.П. Остеопороз//Клин. мед. -1997. -Т. 75. -№6. -С. 20-23.

56. Лупинович В.Л. Оценка влияния соотношения полиненасыщенных жирных кислот омега 6 и омега 3 в рационе на состав липидов тканей крыс: Дис.канд. мед. наук. -М., 1988. -43 с.

57. Мазуров В.И. Зоткин Е.Г., Шемеровская Т.Г. и др. Особенности развития стероидного остеопороза у больных ревматоидным артритом и возможности его профилактики активными метаболитами витамина D//Ocreonopo3 и остеопатии. -1998. -№3. -С. 28-31.

58. Маколкин В.И., Овчаренко С.И., Шеянов М.В. Факторы, определяющие течение и отдаленные исходы бронхиальной астмы: медикаментозная терапия//Клин. мед. -1997. -Т.75. №7. -С. 59-64.

59. Марков Х.М. О биорегуляторной системе L-аргинин-окись азота//Патол. физиол. и эксперим. терапия. -1996 -№1. -С. 34-39.

60. Марков Х.М. Окись азота в физиологии и патологии почек//Вестн. Росс. Акад. наук. -1996№7. -С. 73-78.

61. Марков Х.М Окись азота и окись углерода новый класс сигнальных молекул//Успехи физиол. наук. -1996. -Т 27. -№4. -С. 30-43

62. Марова Е.И. Классификация остеопороза/Юстеопороз и остеопатии. -1998. -№1. -С. 8-12.

63. Масуев К.А. Эйкозаноиды и бронхиальная астма//Пульмонология. -1993. -№1. -С 78-83.

64. Маянский Д.Н. Патогенез бронхиальной астмы//Тер. арх. -1995. -Т. 67. -№12. -С. 77-80.

65. Маянский Д.Н., Макарова О.П., Шишкина Л.Н. и др. Провоспалительная активность бронхоальвеолярной лаважной жидкости при обострении хронических заболеваний легких//Пульмонология. -1998. -№4. -С. 44-50.

66. Меньшикога Е.Б., Зенков Н.К. Окислительный стресс при воспалении//Успехи совр. биологии. -1997. -Т. 117. -№2. -С. 155-171.

67. Механизмы воспаления бронхов и легких и противовоспалительная терапия//Под ред. ФедосееваГ.Б., -СПб.: Нордмедиздат, 1998. -688 с.

68. Мозапевский АФ., Яковлев А.А. Смирнова Е.А. Содержание соединений группы просганоидов в крови и слюне детей с хроническими неспецифическими заболеваниями легких//Педиатрия. -1997. -№5. -С. 14-17.

69. Молостова Т.Н. Ингаляционные глюкокортикоиды в лечении больных бронхиальной асмтой//Тер. арх. -1991. -№3. -С. 143-147.

70. Молостова Т.Н. Эффективность применения пульмикорт-турбухалер в лечении больных бронхиальной астмой//Пульмонология. -1994. -№2. -С. 32-8.

71. Москалев М.Н., Шклярова Б.С., Неронов А.Ф. Влияние дитека на перекисное окисление липидов при бронхиальной астме//4 Нац. конгресс по бол-ням органов дыхания: Сб. резюме, -М. -1994. -№1087.

72. Мотус И.Я. О биопсии в пульмонологии//Пульмонология. —1998. -№4. —С. 73-78.

73. Насонов E.JL, Скрипников И.А., Насонова В.А. Проблема остеопороза в ревматологии. Проблема остеопороза в ревматологии, -М.: Стин, 1997. -18 с.

74. Национальная программа «Бронхиальная астма у детей. Стратегия лечения и профилактика»//Москва, 1997.-С 11-21.

75. Невзорова В.А., Гельцер Б.И. Окись азота и гемоциркуляция легких//Пульмонология. -1997. -№2. -С. 80-85.

76. Невзорова В.А., Елисеева Е.В., Зуга М.В. и др. Нитрооксидергические механизмы регуляции бронхов и их значение в патогенезе бронхиальной астмы//Тер. арх. -1998. -Т. 70. -№3. -С. 13-18.

77. Невзорова В.А., Зуга М.В., Гельцер Б.И. Роль окиси азота в регуляции легочных функций//Тер. арх. -1997. -№3. -С. 68-73.

78. Невзорова В.А., Протопопова М.Ю., Елисеева Е.В. и др. НАДФ Н-диафоразная активность эпителия дыхательных путей при бронхиальной астме/ТПульмонология.1997. -№2. -С. 68-71

79. Непомнящих Г.И., Непомнящих JI.M. Морфогенез и прижизненная патоморфологическая диагностика хронических патологических процессов в легких//Пульмонология. -1997. -№2. -С. 7-16.

80. Овчаренко С.И., Елисеев О.М. Астма и хронические обструктивные заболевания легких. Проблемы диагностики и лечения//Тер. арх. -1997. №8. -С. 64-65.

81. Овчаренко С.И., Шеянов М.В., Маколкин В.И. Факторы риска и пути предотвращения ранних неблагоприятных исходов бронхиальной астмы//Тер. арх.1998. -Т. 70. -№3. -С. 18-22.

82. Овчаренко С.И., Шеянов М.В., Маколкин В.И. Факторы, определяющие отдаленные исходы бронхиальной астмы: роль качества медицинской помощи и обучения пациентов//Тер. арх. -1996. -Т. 68. -№3. -С. 41-44.

83. Оганов B.C. Гипокинезия фактор риска остеопороза/Юстеопороз и остеопатии. -1998. -№1.-С. 13-17.С

84. Папаян А.В., Бенаменьо Ж.П., Сомов Е.Е. и др. Стероидная катаракта при нефротическом синдроме у детей//Педиатрия. -1993. -№3. -С. 94-97.

85. Петров В.И., Смоленое И.В., Аликова О.А. и др. Дозозависимые эффекты флютиказона пропионата у детей с тяжелым течением бронхиальной астмы//Пульмонология. -1999. -№3. -С. 75-82.

86. Петров В.И., Смоленов И.В., Медведева С.С. и др. Качество жизни детей с бронхиальной астмой: влияние базисной противовоспалительной терапии//Аллергология. -1999. -№4. -С. 4-10.

87. Петров В.И., Смоленов И.В., Смирнов Н.А. Безопасность и побочные эффекты ингаляционных кортикостероидов у детей с бронхиальной астмой//Пульмонология. -1998. -№3. -С. 88-95.

88. Польнер С.А. Влияние глюкокортикоидных препаратов бекотида и бекодиска на реактивность бронхов у больных бронхиальной астмой//Клин. мед. -1997. -Т. 75. -№б. -С. 44-46.

89. Порядин Г.В., Самсонов А Н., Балаболкин И.И. и др Новый подход к оценке гиперреактивности бронхов у детей, больных бронхиальной астмой//Педиатрия. -1994. -№6. -С. 5-7.

90. Прасолова Н.И. Стероидная зависимость у больных бронхиальной астмой (возможные причины и пути ее устранения): Дис. канд. мед. наук. М., 1991. -34 с.

91. Прахин Е.И., Прохоренков В.И., Терещенко С.Ю. Роль структурно-функционального состояния мембран в патогенезе различных нозологических форм атопических заболеваний у детей//Педиатрия. -1997. -№2. -С. 14-19.

92. Прахин Е.И., Терещенко С.Ю. Липиды плазматических мембран и липидные медиаторы воспаления у детей с атопическими заболеваниями роль в патогенезе и возможные пути коррекции//Педиатрия. -2000. -№2. -С. 82-88.

93. Реброва Р.Н. Грибы рода Candida при заболеваниях негрибковой этиологии, -М.: Медицина, 1989. -11-16 с.

94. Резник И.Б., Щербина А.Ю., Кулак Ю.В. и др. Особенности воспаления дыхательных путей при бронхиальной астме у детей//Педиатрия. -1997. -№2. -С. 9-14.

95. Ремизов О.В. Поражение опорно-двигательной системы у детей, больных сахарным диабетом: Автореф. дис. канд. мед. наук. -М., 1998. -9-18 с.-ч I45#v>-Г V 'г

96. Ремизов О.В., Мач Э.С., Пушкова О.В. и др. Состояние костно суставной системы при сахарном диабете у детей//Остеопороз и остеопатии. -1999. -№3. -С. 1822.

97. Рожинская Л.Я., Марова Е.И. Эндокринологические аспекты остеопороза//3-й Всероссийский съезд эндокринологов: тезисы докладов. -М, 1996. -С. 199-200.

98. Романова Л.К., Овчаренко С.И., Младковская Т.Б. и др. Особенности клеточных реакций в легких во время обострения бронхиальной астмы//Пульмонология. -1992. -№1. -С. 20-27.

99. Святкина О.Б., Тулуевская Л.М., Погомий Н.Н. и др.//Педиатрия. -1983. -№12. -С. 15-18.

100. Северина И.С. Растворимые формы гуанилатциклаз, механизм активации оксидом азота, роль в агрегации тромбоцг~ов//Вестн. Росс. Акад. мед. наук. -1995. -№2. -С. 41-46.

101. Степанян И.Э. Вопросы ингаляционной кортикостероидной терапии больных бронхиальной астмой//Тер. арх. -1997. -Т. 69. -№8. -С. 60-62.

102. Страчунский Л.С., Суина З.М. Применение бекотида в высоких дозах при бронхиальной астме//Клин. фарм. и терапия. -1993. -№1. -С. 37-38.

103. Суточникова О,А, Чеоняк А.В., Дмитров Е.В., Чучалин А.Г. Противовоспалительная активность отечественного ингаляционного кортикостероида будесонида//Пульмонология. -1995. -№3,- С. 46-48.

104. Суточникова О.А., Самсонова М.В., Черняк А.В., Черняев А.Л. Ингаляционная глюкокортикостероидная терапия больных бронхиальной астмой легкого течения. Влияние на воспаление и гиперреактивность//Пульмонология. -1996. -№4. -С. 21-27.

105. Суточникова О.А, Черняев А.Л., Чучалин АГ. Ингаляционные глюкокортикостероиды при лечении бронхиальной астмы//Тер. арх. -1995. -№11. -С. 78-83.

106. Татарский А.Р. Алиева К.М. Тромбоциты, физиологическая активность. Роль в патогенезе бронхиальной атсмы//Пульмонология. -1991. -№2. -С. 48-54.

107. Терещенко С.Ю. Клинико-прогностическая оценка структурно-функционального состояния мембран эритроцитов у детей, страдающих атопическими заболеваниями: Дис.канд. мед. наук. -Красноярск, 1996. -102 с.

108. Терещенко Ю.А., Тисленко JI.H., Ванетик Е.И. Ингаляционный глюкокортикостероид ингакорт при лечении бронхиальной астмы: эффективность длительной терапии/Яер. арх. -1998. -Т. 70. -№3. -С. 26-29.

109. Трофимова В.И. Особенности формирования бронхообструкгивного синдрома у больных бронхиальной астмой при нарушении гормонального гомеостаза: Дне.д-ра. мед. наук. -СПб., 1990. -78 с.

110. Тугуд Дж. X. (Toogood J.H.) Побочные эффекты лечения ингалируемыми стероидами больных астмой/Яер. арх. -1995. -№10. -С. 76-80.

111. Федоров И.А. Характеристика воспалительного процесса в бронхиальном дереве у детей при тяжелых формах бронхиальной астмы в фазу ремиссии//Пульмонология. -1999. -№1. -С. 63-67.

112. Федосеев Г.Б. Яковлева Н.В., Вишнякова А.В. и др. Механизмы воспаления бронхов и легких и противовоспалительная терапия, -СПб: Нордмед-Издат, 1998. -26 с.

113. Цой А.Н. Параметры фармакокинетики современных ингаляционных глюкокортикостероидов//Пульмонология. -1999. -№2. -С. 73-79.

114. Цой А.Н., Гафуров М.С. Эффективность и безопасность применения препарата пульмикорт турбухалер 1000 мкг/сутки у больных с обострением бронхиальной астмы, ранее не получавших ингаляционных глюкокортикостероидов//Пульмонология. -1999. -№1. -С. 71-76.

115. Цой А.Н., Шор О.А. Динамика ОФВ1 в период длительного лечения антиастматическими препаратами и после их отмены/ЯТульмонология. -1995. -№4. -С. 42-46.

116. Цой А.Н., Шор О.А., Гафуров М.С. Эффективность ингаляционных глюкокортикостероидов при различном режиме дозирования и в комбинации с препаратами теофиллина у больных бронхиальной астмой/Яер. арх. -1997. -Т. 69. -№3. -С. 27-30.

117. Черняев A.JI. Некоторые вопросы патогенеза и патологической анатомии бронхиальной астмы//Архив патологии. -1998. -№2. -С. 63-69.

118. Черняк А.В. Влияние fc агонисгов на бронхиальную гиперреактивность у больных бронхиальной астмой: Дне.канд. мед. наук. -М., 1996. -78 с.

119. Черняк А.В. Влияние отечественных 02 агонистов на гиперреактивность дыхательных путей//Пульмонология. -1996. -№4. -С. 46-51.

120. Чучалин А.Г. Бронхиальная астма, -М: Медицина, 1998. Т.1. -158 с.

121. Чучалин А.Г., Калманова Е.Н., Айсанов З.Р. и др. Применение фиксированных комбинаций ингаляционных кортикостероидов и длительно действующих 02 агонистов в лечении бронхиальной астмы//Пульмонология. -2000. -№6. -С. 81-85.

122. Чучалин А.Г., Молостова Т.Н. Оценка эффективности будесонида у больных бронхиальной астмой двойным слепым перекрестным плацебо-контролируемым методом//Клин. фарм. и терапия. -1993. -№1. -С. 23-26

123. Чучалин А.Г., Черняк Б.А, Медникова О.Б. и др. Эффективность сочетанного применения флутиказона пропионата и сальметерола при 18-месячной терапии больных стероидзависимой бронхиальной астмой//Пульмонология. -1998. -№3. -С. 64-70.

124. Шеянов М.В., Овчаренко С.И., Маколкин В.И. Влияние кортикостероидной терапии на отдаленные исходы бронхиальной астмы//Пульмонология. -1995. -№4. -С 64-67.

125. Шмушкович Б.И. Кортикозависимая бронхиальная астма (Вопросы клиники, осложнений, патогенеза и лечения): Дис.д-ра мед наук. -Москва, 1995. -68 с.

126. Яценко В.П., Брюзгина Т.С., Хоменко В.Е. и др.//Клин. лаб. диагностика. -1997. -№4. -С. 16-17.

127. Abrukteish F., Kirkpatrick J.N.P., Russell G. Posterior subcapsular cataract and inhaled corticosteroid therapy//Thorax. -1995. -Vol. 50. -P. 674-676.

128. Adcock I.M., Brown C.R., Kwon O.J. et al. Oxidative stress induces NF-kB DNA binding and inducible NOS mRNA in human epithelial cells// Biochem. Biophys. Res. Commun. -1994. -Vol. 199. -P. 1518-1524.

129. Adkins K.K., Levan T.D., Miesfeld R.L. et al. Glucocorticoid regulation of GM -CSF: evidence for transcriptional mechanisms in airway epithelial cells//Am. J. Physiol. -1998 Aug. -Vol. 275. -№2 (Ptl). -P. 372-378.

130. Agertoft L., Pedersen S. A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler//J. Allergy. Clin. Immunol. 1997 Jun. -Vol. 99. -№6 (Ptl). -P. 773-780.

131. Agertoft L., Pedersen S. Bone growth and collagen markers in children treated with fluticasone propionate and budesonide//Eur. Respir. J. -1996. -Vol. 9. -Suppl. 23. -P. 295.

132. Agertoft L., Pedersen S. Effects of long-term treatment with an inhaled corticosteroids on growth and pulmonary function in asthmatic children//J.Respir. Med. -1994.-Vol. 88.-P. 373-381

133. Agertoft L., Pedersen S. Importance of the inhalation device on the effect of budesonide//Arch. Dis. Child. -1993. -Vol. 69. -P. 130-133.

134. Ali Baki, Giilay Karaguzel. Short-term effects of budesonide, nedocromil sodium & salmeterol on bronchial hyperresponsiveness in childhood asthma//Acta Paediatrica. Japonica. -1998. -Vol. 40. -P. 247-251.

135. Allen D.B. Growth suppression by glucocorticoid therapy/ZEndocrinol. Metab. Clin. North. Am. -1996 Sep. -Vol 25. -№3. -P. 699-717.

136. Allen D.B. Limitation of short-term studies in predicting long-term adverse effects of inhaled corticosteroids//Allergy. -1999. -Vol. 54. -Suppl. 49. -P. 29-34

137. Allen D.B., Mullen M.L., Mullen B.A A meta-analysis of the effect of oral and inhaled corticosteroids on growth//! Allergy. Clin. Immunol. -1994. -Vol. 93. -№6. -P. 967976

138. Allen M.B., Ray S.G., Leitch A.G. et al. Steroid aerosols and cataract formation// Brit. Med. J. -1989. -Vol. 299. -P. 432-433.

139. Andersson N, Klint S., Randwall G., Wiren J.E. Equipotency of BUD and fluticasone propionate in the vasoconstriction assay//Am. J. Respir. Crit. Care. Med. -1994 -Vol. 49. (Suppl.). -№4 (Pt2). -P. 467.

140. Andersson P., Ryrfeldt A. Biotransformation of the topical glucocorticoids budesonide and beclomethasone 17alpha,21-dipropionate in human liver and lung homogenate//J. Pharm. Pharmacol. -1984. -Vol. 36. -P. 763-765.

141. Andresen M., Diaz O., Troncoso S. Nitric oxide and respiratory diseases//Rev. Med. Chil. -1997 Aug. -Vol. 125. -№8. -P. 935-938.

142. Arnon S., Grigg J., Silverman M. Effectiveness of budesonide aerosol in ventilator-dependent preterm babies: a preliminary report/ZPediatr. Pulmonol. -1996 Apr. -Vol. 21. -№4. -P. 231-235.

143. Aubert J.D., Quadri F., Soler M. Insufficient control of asthma: increase the dose of inhaled steroids or add long-acting beta 2-agonists?//Schweiz. Med. Wochenschr. -1997 Feb. -Vol. 127. -№5. -P. 176-181.

144. Augusti M.B., Clara P.C. Dysphoria induced by corticoid inhalation. Truth or myth?//Arch. Bronchoneumol. -1995. -Vol. 31. -№8. -P. 415-417.

145. Backman K.S., Greenberger P.A., Patterson R. Airways obstruction in patients with long-term asthma consistent with 'irreversible asthma'//Chest. -1997 Nov. -Vol. 112. -№5. -P. 1234-1240.

146. Bancalari L., Dente F.L., Carletti A. et al. Effect of salmeterol on eosinophilic count in induced sputum after late airway response to allergen inhalation in asthmatic subjects//Allergy and Asthma. -1996. -Vol. 16. -№5. -P 42.

147. Baraldi E., Azzolin N.M., Zanconato S. et al. Corticosteroids decrease exhaled nitric oxide in children with acute asthma//! Pediatr. -1997. -Vol. 131. -№3. -P. 381-385.

148. Baran D., Faulkner K., Genant H Et al Diagnostic & treatment of osteoporosis//Calcified. Tissue. Int. -1997. -Vol. 3. -№151. -P. 433-440.

149. Baraniuk J., Murray J.J., Nathan R.A. et al. Fluticasone alone or in combination with salmeterol vs triamcinolone in astma//Chest. -1999 Sep. -Vol. 116. -№3. -P. 625-632.

150. Barenholtz H. Effect of inhaled corticosteroids on the risk of cataract formation in patients with steroid-dependent asthma//Ann. Pharmacother. -1996. -Vol. 30. -P. 13241327.

151. Barnes N.C. A comparison of fluticasone propionate, 1 mg daily with beclomethasone dipropionate , 2 mg daily, in the treatment of severe asthma//Eur. Respir. J. -1993.-Vol. 6.-P. 877-884.

152. Barnes N.C. Safety of high-dose inhaled corticosteroids/ZRespir. Med. -1993. -Vol. 87. -Suppl. A. -P.27-31.

153. Barnes N.C., Thwaites R.M., Price M.J. The cost-effectiveness of inhaled fluticasone propionate and budesonide in the treatment of asthma in adults and children//Respir. Med. -1999 jun. -Vol. 93. -№6. -P. 402-407.

154. Barnes P. Biomarkers for inflammation. Biomarkers in COPD//Sixth Ann. Congress Europ. Respir. Soc. -Abstracts. -1996. -P. 11-13.

155. Barnes PJ. Current issues for establishing inhaled corticosteroids as the antiinflammatory agents of choice in asthma// J. Allergy. Clin. Immunol. -1998 Apr. -Vol. 101. -№4 (Pt2). -P. 427-433.

156. Barnes P.J. Current therapies for asthma. Promise and limitations//Chest. -1997 Feb. -Vol. 111. -Suppl. 2. -P. 17-26.

157. Barnes P.J. Effect of corticosteroids on airway hyperresponsiveness//Am. J. Respir. Dis. -1990. -Vol. 141. -P. 70-76.

158. Barnes P.J. Efficacy of inhaled corticosteroids in asthma//J. Allergy Clin. Immunol. -1998 Oct. -Vol. 102 (4 Pt 1). -P. 531-8.

159. Barnes P.J. Mode of action of steroids in asthma//Corticosteroid therapy in asthma & rhinitis//Ann. Int. Symp., Australia. -1991. -P. 7-10.

160. Barnes P.J. New concepts in the pathogenesis of brorchial hyperresponsiveness & astma//J. Allergy. -1989. -Vol. 83. -№6. -P. 1013-1026.

161. Barnes P.J. Nitric oxide and airway disease//Ann. Med.-1995 Jun.-Vol. 27. -№3. -P. 389-393.

162. Barnes P.J. NO or no NO in asthma//Thorax. -1996. -Vol. 51. -P. 218-22.

163. Barnes P.J., Adcock I.M. Anti-inflammatory actions of steroids: molecular mechanisns//Trends. Pharmacol. Sci. -1993. -№14. -P. 436-441.

164. Barnes P.J., Liew F.Y. Nitric oxide and asthmatic inflammation//Immunol. Today. -1995. -Vol. 16. -P. 128-130.

165. Barnett P.L., Caputo G.L., Baskin M. et al. Intravenous versus oral corticosteroids in the management of acute asthma in children//Ann. Emerg. Med. -1997 Feb. -Vol. 29. -№2. -P. 21.2-217.

166. Bateman E.D., Britton M., Carrillo J. et al. Salmeterol/fluticasone combination inhaler: a new, effective and well tolerated treatment for asthma//Clin. Drug. Invest. -1998. -Vol. 16. -P. 193-201.

167. Beck J., Griese M., Latzin P. et al. Characteristics of flow dependency of nitric oxide in exhaled air in children with cystic fibrosis and asthma//Eur. J. Med. Res. -1999 Aug. -Vol. 4. -№8. -P. 335-340.

168. Belvisi M.G., Stretton C.D., Barnes P.J. et al. Nitric oxide is the endogenous neurotransmitter of bronchodilatator nerves in human airways//Eur. J. Pharmacol. -1992. -Vol. 210. -P. 221-222.

169. Bergmann K.C. Controlled clinical comparative evaluation of fluticasone powder inhalation versus flunisolide dose aerosol in patients with mild to moderate asthma//Pneumologie. -1997 Jan. -51. -№1. -P. 27-32.

170. Bettendorf М., Albers N. Bauer J. et al. Longitudinal evaluation of salivary Cortisol levels in full-term and preterm neonates//Horm. Res. -1998. -Vol. 50. -№6. -P 303308.

171. Binz K., Schmid C., Bouillon R. et al. Interactions of insulin-like growth factor I with dexamethasone on trabecular bone density & mineral metabolism in rats//Eur. J. Endocrinol. -1994. -Vol. 130. -P. 387-393.

172. Bisgaard H. Systemic activity of inhaled topical steroid in toddlers studied by knemometry//Acta Paediatr. Int. J. Paediatr. -1993. -Vol. 82. -№2. -P. 1066-1071.

173. Bisgaard H., Nielsen M.D., Andersen B. et al. Adrenal function in children with bronchial asthma treated with beclomethasone dipropionate or budesonide//J. Allergy Clin. Immunol. -2988. -Vol. 81. -P. 1088-1095.

174. Bjornsson E., Janson C., Hakansson L. et al. Serum eosinophil peroxidase in allergic & non-allergic asthma//Europ. Respir. J. -1993. -Vol. 6. -S. 17. -P. 1106.

175. Boer J., Duyvendak M, Schuurman F.E. et al. Role of L-arginine in the deficiency of nitric oxide and airway hyperreactivity after the allergen-induced early asthmatic reaction in guinea-pigs//Br. J. Pharvacol. -1999 Nov. -Vol. 128. -№5. -P. 11141120.

176. Boer J., Meurs H., Coers W. et al. Deficiency of nitric oxide in allergen-induced airway hyperreactivity to contractile agonists after the early asthmatic reaction: an ex vivo study//Br. J. Pharmacol. -1996 Nov. -Vol. 119. -№6. -P. 1109-1116.

177. Boer J., Pouw F.M., Zaagsma J. et al. Effects of endogenous superoxide anion and nitric oxide on cholinergic constriction of normal and hyperreactive guinea pig airway//Am. J. Respir. Crit Care. Med. -1998 Dec. -Vol. 158. -№6. -P. 1784-1789.

178. Bojic M., Rascovic S., Peric-Popadic A. et al. Leukotrienes in allergic inglammatory reactions//Srp. Arh. Celok Lek. -1998 Sep-Oct. -Vol. 126. -№9-10. -P. 382387.

179. Boner A.L., Piacentini G.L. Inhaled corticosteroids in children: Is there a "safe" dosage?//Drug Saf. -1993. -Vol. 9. -№1. -P. 9-20.

180. Booms P., Cheung D., Timmers M.C et al. Protective effects of inhaled budesonide against unlimited airway narrowing to methacholine in atopic patients with asthma//J. Allergy. Clin. Immunol. -1997 Mar. -Vol. 99. -№3. -P. 330-7.

181. Booth H., Richmond I., Ward C. et al. Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma//Am. J. Respir. Crit. Care Med. -1995 Jul -Vol. 152. -№1. -P. 45-52.

182. Bootsma G.P., Koenderman L., Dekhuijzen P.N. et al. Effects of fluticasone propionate and beclomethasone dipropionate on parameters of inflammation in peripheral blood of patients with asthma//Allergy. -1998 Jul. -Vol. 53. -№7. p. 653-661.

183. Bomefalk E., Dahlen I., Michaelsson K. et al. Age-dependent effect of oral glucocorticoids on markers of bone resorption in patients with acute asthma//Calcif Tissue Int. -1998 Jul. -Vol. 63. -№1. -P. 9-13.

184. Boulet LP., Laviolette M., Turcotte H. et al. Bronchial subepithelial fibrosis correlates with airway responsiveness to methacholine//Chest. -1997 Jul. -Vol. 112. -№1. -P. 45-52.

185. Bousquet J., Chanes P., Lacoste J. et al. Eosinophilic inflammation in asthma//N. Engl. J. Med. -1990. -Vol. 323. -P. 1033-1040

186. Bowton D.L., Seeds M.C., Fasano M.B. et al. Phospholipase A2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics//Am. J. Respir. Crit. Care Med. -1997 Feb. -Vol 155. -№2. -P. 421-425

187. Brand P.L., Hoekstra M.O. Diagnosis and treatment of recurrent coughing and wheezing in children younger than 4 years old//Ned-Tijdschr-Geneeskd. -1997 Mar. -Vol. 141. -№10. -P. 464-467.

188. Brandli D.W., Golde G., Greenwald M. et al. Glucocorticoid-induced osteoporosis: a cross-sectional study//Steroids. -1991. -Vol. 56. -№10. -P. 518-23.

189. Brattsand R. Development of glucocorticoids with lung selectivity. In: Hargreave F.E., Hogg J.C., Malo J-L., Toogood J.H. (eds). Glucocorticoids and mechanisms of asthma. Amsterdam: Excerpta Medica, 1989. -17-38 p.

190. Brattsand R., Axelsson B.I. New inhaled glucocorticosteroids. In: Barnes P.J. (ed). New drugs for asthma. Volume 2, Chapter 13. London, 1992. -193-208 p.

191. Brattsand R., Selroos O. Current drugs for respiratory diseases: glucocorticosteroids. In: page C.P., Metzger W.I. (eds). Drugs and the lung. New York: Raven Press Ltd, 1994. -101-220 p.

192. Brattsand R., Thalen A., Roempke K. et al. Development of new glucocorticosteroids with a very high ratio between topical and systemic activities//Eur. J. Respir. Dis. -1982. -Vol. 63. -Suppl. 122. -P. 62-73.

193. Brewster C.E.//Am. J. Resp. Cell Molecular Biol. -1990. -Vol. 3. -P. 507-511.

194. Brunette M. G., Lands L., Thibodeau L.P. Childhood asthma: Prevention of attacks with short-term corticosteroid treatment of upper respiratory tract infection//Paediatrics. -1998. -Vol. 81. -P. 624-629

195. Burke C., Power C.R., Norris A. et al. Lung function immunopathological changes after inhaled corticosteroid therapy in asthma//Eur. Respir. J. -1992. -Vol. 5. -P. 73-79.

196. Burke C.M., Sreenan S., Pathmakanthan S. et al. Relative effects of inhaled corticosteroids on immunopathology and physiology in asthma: a controlled study//Thorax. -1996 oct. -Vol. 51. -№10. -P. 993-999.

197. Busse W.W. Inflammation in asthma: the cornerstone of the disease and target of therapy//! Allergy Clin. Immunol. -1998 Oct. -Vol. 102. -№4 (Pt2). -P. 17-22.

198. Busse W.W. Leukotrienes and inflammation//Am. J. Respir. Crit. Care Med. -1998 Jun. -Vol. 157. -№6 (Pt2). -P. 210-213.

199. Butler G.B., Adler K.B., Evans J.N. et al. Modulation of rabbit airway smooth muscle responsiveness by respiratory epithelium//Am. Rev. Respir. Dis. -1987. -Vol. 135. -P. 1099-1104.

200. Carter P.M., Heinly T.L., Yates S.W. et al. Asthma: the irreversible airways disease//! Investig. Allergol. Clin. Immunol. -1997 Nov-Dec. -Vol. 7. -№6. -P. 566-571.

201. Catena E., Mazzarella G., Peluso G. et al. Phenotypic features & secretory pattern of alveolar macrophages in atopic asthmatic patients/ZMonaldi Arch. Chest Dis. -1993. -Vol. 48. -P. 6-15.

202. Chaplin M.D., Rooks I.I., Swenson E.W. et al. Flunisolide metabolism and dynamics of a metabolite//Clin. Pharmacol. Ther. -1980. -Vol. 27. -P. 402.

203. Chapman K.R., Ringdal N., Backer V. et al. Salmeterol and fluticasone propionate (50/250mcg) administrated via combination Discus inhaler: as effective as when given via separate Discus inhaler//Can. Respir. J. -1999. -Vol. 6. -№1. -P. 45-51.

204. Chavis C., Chanez P., Vachier I. et al. 5-15diHETE and lipoxins generated by neutrophils from endogenous arachidonic acid as asthma biomarkers/ZBiochem. Biophys. Res. Commun. -1995 Feb. -Vol. 207. -№1. -P. 273-279.

205. Chavis C., Vachier I., Bousquet J. et al. Generation of eicosanoids from 15 (S)-hydroxyeicosatetraenoic acid in blood monocytes from steroid-dependent asthmatic patients//Biochem-Pharmacol. -1998 Aug. -Vol. 56. -№4. -P. 535-41.

206. Chetta A., Foresi A., Del-Donno M. et al. Airways remodeling is a distinctive feature of asthma and is related to severity of disease//Chest. -1997 Apr. -Vol. 111. -№4. -P. 852-857.

207. Chung K.F., Becker A.B., Lazarus S.C. et al. Antigen-induced airway hyperresponsiveness and pulmonary inflammation in allergic dogs//J. Appl. Physiol. -1985. -Vol. 58. -P. 1347-1353.

208. Churh M.K., Hiroi J. Inhibition of IgE-dependent histamine release from human dispersed lung mast cell by antiallergic drugs and salbutamol//Br. J. Pharmacol. -1987. -Vol. 90. -P. 421-429.

209. Chylack L.T. Cataracts and inhaled corticosteroids//N. Engl. J. Med. -1998. -Vol. 337. -№1. -P. 46-48.

210. Clark D.J., Lipworth B.J. Dose-response of inhaled drugs in asthma. An update//Clin. Pharmacokinet. -1997 Jan. -Vol. 32. -№1. -P. 58-74.

211. Coceani F., Olley P.M. Eicosanoids in the fetal and transitional pulmonary circulation//Chest. -1988. -Vol. 93. -P. 112-117.

212. Cockroft D.W., Ruffin R.E., Dolovich J. et al. Allergen-induced in nonallergic bronchial reactivity//Clin. Allergy. -1977. -Vol. 7. -P. 503-513.

213. Connett G., Lenney W. Prevention of viral induced asthma attacks using inhaled budesonide//Arch. Dis. Child . -1993. -Vol. 68. -P. 85-87.

214. Corrigan C., Kay A. The roles of inflammatory cells in the pathogenesis of asthma & of COPD//Am Rev Respir Dis. -1991. -Vol. 143. -Suppl. -P. 1165-1168.

215. Corryn B. Pathology of interstitial lung disease//Am. J. Respir. Crit. Care Med. -1994. -Vol. 15. -№61. -P. 76.

216. Crimi E., Spanevello A., Neri M. et al. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma//Am. J. Respir. Crit. Care Med. -1998 Jan. -Vol. 157. -№1. -P. 4-9.

217. Crowley S., HindmarshP.C., Holownia P. et al. The use of low doses of ACTH in the investigation of adrenal function in man//J. Endocrinol. -1991. -Vol. 130. -P. 425-429.

218. Cumming R.G., Mitchell P., Leeder S.R. Use of inhaled corticosteroids and risk of cataracts//N. Engl. J. Med. -1998. -Vol. 337. -№1. -P. 8-14.

219. Dahl R. Are beta2-adrenergic agonists "antiinflammatory"?//Europ. Res. J. -1991. -Vol. 4, Suppl. 14. -P. 89-93.

220. Dahl R. Efficacy of fluticasone propionate in adult asthma/ZEurop. Res. J. -1992. -Vol.15. -№5. -P. 1085-1089.

221. Dahl R., Johansson S.F. Clinical effect of b.i.d. and q.i.d. administration of inhaled budesonide. A double-blind controlled study//Eur. J. Respir. Dis. -1995. -Vol. 67. -P.254-260.

222. Dahl R., Ullman A. Efficacy of inhaled corticosteroids//Asthma Management. Topics for the 90s. A Symposium Report Clinical Vision Ltd. 2-nd Ed. -Helsinki, 1994. -P. 18-23.

223. Dahlem S.E., Hedquist P., Hammarstrom S. Contractile activities of several cystein-containing leukotrienes in the guinea-pig lung strip//Eur. J. Pharmacol. -1982. -Vol. 86.-P. 207-215.

224. Das U.N. Possible role of prostaglandins of pulmonary hypertensions/ZProstaglandins. -1980. -Vol. 4. -P. 163-170.

225. Daugberg P. A comparison between nebulised terbutaline, nebulized corticosteroid and systemic corticosteroid for acute wheezing in children up to 18 month of age//Acta Paediatr. -1993. -Vol. 82. -P. 547-551.

226. Davies D.E., Polosa R., Puddicombe S.M. et al. the epidermal growth factor receptor and its ligand family: their potential role in repair and remodelling in asthma//Allergy. -1999 Aug. -Vol. 54. -№8. P. 771-83.

227. De Monchy J.G.R., Kauffman H.F., Venge P. et al. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reaction//Am. Rev. Respir Dis. -1985. -Vol. 131. -P. 373-376.

228. De-Benedictis F.M., Martinati L.C., Solinas L.F. et al. Nebulized flunisolide in infants and young children with asthma: a pilot study//Pediatr. Pulmonol. -1996 May. -Vol. 21.-№5.-P. 310-315.

229. De-Gouw H.W., Verbruggen M.B., Twiss I.M. et al. Effect of oral L-arginine on airway hyperresponsiveness to histamine in asthma//Thorax. -1999 Nov. -Vol. 54. -№11. -P. 1033-1035.

230. Delany A.M., Dong Y., Canalis E. Mechanisms of glucocorticoid action in bone cells//! Cell Biochem. -1994. -Vol. 56. -№3. -P. 295-302.

231. Demoly P., Jafluel D., Chung K.F. et al. Pharmacological specificities and modalities of prescription for corticoids for asthmatic adults/ZPresse Med. -1996 Dec. -Vol. 25. -№40. -P. 2025-2030.

232. Dequeker J., Maenaut K., Verwilghen J. et al. Osteoporosis in rheumatoid arthritis//Brit. J. Rheumatol. -1997. -Vol. 36. -№4. -P. 444-448.

233. Dinakar C., Malur A., Raychaudhuri B. et al. Differential regulation of human blood monocyte and alveolar macrophage inflammatory cytokine production by nitric oxide//Ann. Allergy Asthma Immunol. -1999 Feb. -Vol. 82. -№2. -P. 217-222.

234. Djukanovic R., Homeyard S., Gratziou S. et al. The effect of treatment with oral corticosteroids on asthma symptoms and airway inflammation//Am. J. Respir. Crit. Care Med. -1997 Mar. -Vol. 155. -№3. -P. 826-832.

235. Dooper M.W., Timmermans A., Aalbers R. et al. Production of diacylglycerol and arachidonic acid in peripheral blood mononuclear cells from patients with asthma and healthy controls//Ann. Allergy Asthma Immunol. -1995 Mar. -Vol. 74. -№3. -P. 249-254.

236. Doull I.J.M., Freezer N. J., Holgate S.T. Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate//Am. J. Respir. Crit. Care Med. -1995. -Vol. 151. -№6. -P. 1715-1719.

237. Downey G.P., Worthen G.S., Henson P.M. et al. Neutrophil sequestration & migration in localized pulmonary inflammation//Am. Rev. Respir. Dis. -1993. -Vol. 147. -P. 168-176.

238. Drazen J.M. Leukotrienes as mediators of airway obstruction//Am. J. Respir. Crit. Care Med. -1998 Nov. -Vol. 158. -№5 (Pt 3). -P. 193-200.

239. Du J., Cui D., Tian D. The role of nitric oxide in the pathogenesis of asthma//Chung Hua Chieh Ho Ho Hu Hsi Tsa Chih. -1997 Jun. -Vol. 20. -№3. -P. 153-156.

240. Dunill M.S. The pathology of asthma with special reference to changes in the bronchial mucosa//! Clin. Pathol. -1960. -Vol. 13. -P. 27-33.

241. Dupont L.J., Rochette F., Demedts M.G. et al. Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma//Am. J. Respir. Crit. Care Med. -1998 Mar. -Vol. 157. -№3 (Ptl). -P. 894-898.

242. Durham S.R, Craddock C.F., Cookson W.O. et al. Increases in airway responsiveness to histamine precede allergen-induced late asthmatic responses//! Allergy Clin. Immunol. -1988. -Vol. 82. -P. 764-770.

243. Ebeling P.R., Erbas В., Hopper J.L. et al. Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids//!. Bone Miner. Res. -1998 Aug. -Vol. 13. -№8. -P. 1283-1289.

244. Ebina M., Takahashi Т., Chiba T. et al. Cellular hypertrophy & hyperplasia of airway smooth muscle underlying bronchial asthma. A 3-D morphometry study//Am. Rev. Respir. Dis. -1993. -Vol. 148. -P. 720-6.

245. Ece F., Есе Т., Yilmaz A. et al. The assessment of the efficacy of salmeterol and beclomethasone dipropionate measuring serum eosinopnil cationic protein levels//Allergy and Asthma. -1996. -Vol. 13. -№5. -P. 53.

246. Edsbacker S., Andersson P., Lindberg C. et al. Metabolic acetal splitting of budesonide. A novel inactivation pathway for topical glucocorticoids//Drug Metab. Dispos. -1987. -Vol. 15. -P. 412-417.

247. Eggleston P., Kaggey-Sobotka A., Proud D. et al. Dissociation of the release of histamine & arachidonic acid metabolites from osmotically activated basophiles & human lung mast cells//Amer. Rev. Respir. Dis. -1990. -Vol. 141. -P. 960-964.

248. Eseverri J.L., Botey J., Marin A.M. Budesonide: treatment of bronchial asthma during childhood//Allergy Immunol. Paris. -1995 Apr. -Vol. 27. -№4. -P. 129-135.

249. Evans D.J., Taylor D. A., Zetterstrom O. et al. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma//N. Engl. J. Med. -1997 Nov. -Vol. 337. -№20. -P. 1412-1418.

250. Evans M., O'Connor D.J., Fuller R.W. et al. Effect of inhaled budesonide on eosinophil density in asthma//Br. J. Clin. Pharmacol. -1991. Vol. 31. -P. 616.

251. Fabbri L.M., Papi A, Corbetta L. et al. The therapy of bronchial asthma/ZRecenti Prog. Med. -1999 May. -Vol. 90. -№5. -P. 271-279.

252. Fahy J.V., Boushey H.A. Effect of low-dose beclomethasone dipropionate on asthma control and airway inflammation//Eur. Respir. J. -1998 Jun. -Vol.11. -№6. -P. 12401247.

253. Fahy J. V., Steiger D.J., Liu J. et al. Markers of mucus secretion and DNA levels in induced sputum from asthmatic and from healthy subjects//Am. Rev. Respir. Dis. -1993 May. -Vol. 147. -№5. -P. 1132-1137.

254. Fairfax AJ., David V., Douce G. Laryngeal aspergillosis following high dose inhaled fluticasone therapy for asthma//Thorax. -1999 Sep. -Vol. 54. -№9. -P. 860-861.

255. Falcoz C., Mackie A.E., McDowall J. et al. Oral bioavailability of fluticasone propionate in healthy subjects//Br. J. Clin. Pharmacol. -1996. -Vol. 41. -P. 459-460.

256. Faul J.L., Leonard C.T., Burke C.M. et al. Fluticasone propionate induced alterations to lung function and the immunopathology of asthma over time//Thorax. -1998 Sep. -Vol. 53. -№9. -P. 753-761.

257. Feldman D., Funder J., Loose D. Is the glucocorticoid receptor identical in various target organs?//! Steroid Biochem. -1978. -Vol. 9. -P. 141-145.

258. Feresia, Bertorelli G., Pesci A. et al. Inflammatory markers in bronchoalveolar lavage and in bronchial biopsy in asthma during remission//Chest. -1990. -Vol. 98. -P. 528535.

259. Ferguson A.C., Spier S., Manjra A. et al. Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide//! Pediatr. -1999 Apr. -Vol. 134. -№4. -P. 422-427.

260. Ferguson A.C., Whitelaw M., Brown H. Correlation of bronchial eosinophils and mast cell activation with bronchial hyperresponsiveness in children with asthma/Д. Allergy Clin. Immunol, -1992. -Vol. 90. -P. 609-613.

261. Ferguson A.C., Wong F.W. Bronchial hyperresponsiveness in asthmatic children: correlation with macrophages and eosinophils in bronchoalveolar lavage fluid// Chest. -1999. -Vol. 96. -P. 988-991.

262. Ferreira H.H., Bevilacqua E., Gagioti S.M. et al. Nitric oxide modulates eosinophil infiltration in antigen-induced airway inflammation in rats//Eur. J. Pharmacol. -1998 Oct. -Vol. 358. -№3. -P. 253-259.

263. Flak T.A., Goldman W.E. Autotoxicity of nitric oxide in airway disease//Am. J. Respir. Crit. Care Med. -1996 Oct. -Vol. 154. -№4 (Pt2). -P. 202-206.

264. Flower R.J., Blackwell G.J. Antiinflammatory steroids induce biosynthesis of a phospholipase Аг inhibitor which prevents prostaglandin generation//Nature. -1979. -Vol.278. -P. 456-459.

265. Ford-Hutchinson A.W. Leukotriene involvement in pathologic process//J. Allergy Clin. Immunol. -1984. -Vol. 74. -№2. -P. 437-440.

266. Frenley D.C. Can today's treatment prevent tomorrow's obstruction//Br. J. Clin. Pract. -1988. -Vol. 42. -№2. -Suppl. 59. -P. 25-36.

267. Friday G.A. Jr., Khine H., Lin M.S. et al. Profile of children requiring emergency treatment for asthma//Ann. Allergy Asthma Immunol. -1997 Feb. -Vol. 78. -№2. -P. 221224.

268. Frieri M. Nitric oxide in allergic rhinitis and asthma//Allergy-Asthma-Proc. -1998 Nov-Dec. -Vol. 19. -№6. -P. 349-51.

269. Fuller R., Johnson M., Bye A. Fluticasone propionate an update on preclinical and clinical experience//Respir. Med. -1995 Sep. -Vol. 89. -Suppl. A. -P. 3-18.

270. Gant V., Cluzel M., Shakoor Z. et al. Alveolar macrophage accessory cell function in bronchial asthma//Am. Rev. Respir. Dis. -1998. -Vol. 146. -P. 900-904.

271. Garrett J., Williams S., Wong S. et al. Treatment of acute asthmatic exacerbations with an increased dose of inhaled steroids//Arch. Dis. Child. -1998 Jul. -Vol. 79. -№1. -P. 12-17.

272. Gee M.H., Albertine K.H. Neutrophil-endothelial cell interaction in the lung//Ann. Rev. Physiol. -1993. -Vol. 55. -P. 227-248.

273. Gerdtham U.G., Hertzman P., Jonsson B. et al. Impact of inhaled corticosteroids on acute asthma hospitalization in Sweden 1978 to 1991//Med. Care. -1996 Dec. -Vol. 34. -№12.-P. 1188-1198.

274. Gibson P.G., Mattoli S., Sears M.S. et al. Cellular characteristics of sputum from patients with asthma & chronic bronchitisZZThorax. -1989. -Vol. 44. -P. 693-9.

275. Giep Т., Raibble P., Zuerlein T. et al. Trial of beclomethasone dipropionate by metered-dose inhaler in ventilator-dependent neonates less than 1500 grams//Am. J. Perinatol. -1996 Jan. -Vol. 13. -№1. -P. 5-9.

276. Goldberg S., Algur N., Levi M. et al. Adrenal suppression among asthmatic children receiving chronic therapy with inhaled corticosteroids with and without spacer device//Ann. Allergy Asthma Immunol. -1996 Mar. -Vol. 76. -№3. -P. 234-238.

277. Gomez F.P., Barbera J.A., Roca J. et al. Effect of nitric oxide synthesis inhibition with nebulized L-NAME on ventilation-perfusion distributions in bronchial asthma//Eur. Respir. J. -1998 Oct. -Vol. 12. -№4. -P. 865-871.

278. Goodwin A. Treating childhood asthma with nebulised steroids/ZProf. Care Mother Child. -1995. -Vol. 5. -№1. -P. 7-9.

279. Grandgeorge S., Vaughan L., Milavetz G. et al. Systemic and topical dose-response relationships of inhaled corticosteroids aerosolsZZAnnual Meeting of the American Academy of Allergy and Immunology in Washington. -1987. -Vol. 883. -P. 64-7.

280. Griese M., Schur N., Laryea M.D. et aLZZEurop. J. Pediatr. -1990. -Vol. 149. -№7. -P. 508-512.

281. Grootendorst D.C., Sont J.K., Wfflems L.N. et al. Comparison of inflammatory cell counts in asthma: induced sputum vs bronchoalveolar lavage and bronchial biopsiesZZClin. Exp. Allergy. -1997 Jul. -Vol.27. -№7. -P- 769-779.

282. Gross N.J. Anticholinergic therapy in obstructive airway disease, -London: Franklin Scientific Publ., 1993. -19-23 p.

283. Grossman A. Steroid safety: the endocrinologist's viewZZInt. J. Clin. Pract. Suppl. -1998 Sep. -Vol. 96. -P. 33-38.

284. Grydlewski R.J. Transcellular biosynthesis of eicosanoidsZ/Pol. J. Pharmacol. -1999 Mar-Apr. -Vol. 51. -№2. -P. 113-117.

285. Guo F.H., Comhair S.A., Zheng S. et al. Molecular mechanisms of increased nitric oxide (NO) in asthma: evidence for transcriptional and post-translational regulation of NO synthesis//! Immunol. -2000 Jun. -Vol. 164. -№11. -P. 5970-5980.

286. Haapasaari K., Rossi O., Risteli J. et al. Effects of long-term inhaled corticosteroids on skin collagen synthesis and thickness in asthmatic patients//Eur. Respir. J. -1998 Jan. -Vol.11. -№1. -P. 139-143.

287. Ha-Baik Lee, Jae Won Oh, Ji Hye Kim. Elevated circulating levels of ECP, ICAM-1, VCAM-1, IL-6 and IL-6 receptor and the beneficial effects of inhaled budesonide in children wish asthma//Allergy and Asthma. -1996. -Vol. 16. -№5. -P. 28.

288. Hagan J.B., Kita H., deich G.J. Inhibition of interleukin-5 mediated eosinophil viability by fluticasone 17-propionate: comparison with other glucocorticoids//Clin. Exp. Allergy. -1998 Aug. -Vol. 28. -№8. -P. 999-1006.

289. Haley K.J. Inflammation & airway function in asthma//Am. J. Respir. Crit. Care Med. -1998. -Vol. 157. -P. 1-3.

290. Hamada H., Sakatani M., Ueda E. KL-6 in patients with interstitial pneumonitis//Nihon Kyoby Shikkan Gakkai Zasshi. -1996 Jul. -Vol. 34. -№7. -P. 771-777.

291. Hamid Q., Springall D.R., Riveros-Moreno V. et al. Induction of nitric oxide synthase in asthma/ZLancet. -1993. -Vol. 342. -P. 1510-1513.

292. Harding S.M. The human pharmacology of fluticasone propionate/ZRespir. Med. -1990. -Vol. 84 (Suppl. A). -P. 25-29.

293. Hasegawa S. Clinical significance of serum levels of a carbohydrate antigen, syalyl antigen SSEA-1, in patients with fibrosing lung disease//Am. Rev. Respir. Dis. -1991. -Vol. 144.-P. 1177-1181.

294. Hashimoto Т., Minoguchi K., Kohno Y. et al. Correlation between respiratory function and airway inflammation in asthma/ZInt. Arch. Allergy Immunol. -1999. -Vol. 120, Suppl. 1. -P. 82-85.

295. Henderson W.R. Jr., Lewis D.B., Albert R.K. et al. The importance of leukotrienes in airway inflammation in a mouse model of asthma/ZJ. Exp. Med. -1996 Oct. -Vol. 184. -№4. -P. 1483-1494.

296. Herd C.M., Page C.P. Pulmonary immune cells in health & disease: platelets//Eur. Respir. J. -1994. -Vol. 7. -P. 1145-1160.

297. Herraia J., Puolijoki H., Imprivaara O. et al. Bone mineral density in asthmatic women of high-dose inhaled beclomethasone dipropionate//Bone. -1994. -Vol. 15. -№6. -P, 621-623.

298. Hilgers J., Von Mensdorff—Poully S., Verstraeten A.A. et al. Quantitation of polymorphic epithelial mucin: a challenge for biochemists and immunologist//Scand. J. Clin. Lab. Invest. 1995. -Vol. 55, Suppl. 221. -P. 81-86.

299. Hirata F., Schiffinan E., Venkatasubramanian K. et al. A phospholipase A2 inhibitory protein in rabbit neutrophilis induced by g(ucocorticoids//Proc. Natl. Acad. Sci. USA -1980. -Vol. 77. -P. 2533-2536.

300. Hirst S.J., Lee Т.Н. Airway smooth muscle as a target of glucocorticoid action in the treatment of asthma//Am. J. Respir. Crit. Care Med. -1998 Nov. -Vol. 158. -№5 (Pt 3). -P. 201-206.

301. Hodge W.Y., Whitcher J.P., Satariano W. Risk factors for age-related cataracts/ZEpidemiol. Rev. -1995. -Vol. 17. -P. 336-346.

302. Hoekstra M.O., Grol M.H., Bouman K. et al. Fluticasone propionate in children with moderate asthma//Am. J. Respir. Crit. Care Med. -1996 Oct. -Vol. 154. -№4 (Ptl). -P. 1039-1044.

303. Hoekstra M.O., Grol M.H., Hovenga H. et al. Eosinophil and mast cell parameters in children with stable moderate asthma/ZPediatr. Allergy Immunol. -1998 Aug. -Vol. 9. -№3. -P. 143-149.

304. Hoekx J.C., Hedlin G., Pedersen W. et al. Fluticasone propionate compared with budesonide: A double-blind trial in asthmatic children using powder devices at a dosage from 400 mu g/day (-1)//Eur. Respir. J. -1996. -Vol. 9. -№11. -P. 2263-2272.

305. Hogg J.C. Neutrophil kinetics & lung injury/ZPhysiol. Rev. -1987. -Vol. 67. -P. 1249-1294.

306. Hogger P., Rawert I., Rohdewald P. Dissolution, tissue binding and kinetics of receptor binding of inhaled glucocorticoids//Eur. Respir. J. -1993. -Vol. 6. -Suppl. 17. -P. 584.

307. Hogman M., Frostell C.G., Hedenstrom H. et al. Inhalation of nitric oxide modulates adult human bronchial tone//Am. Rev. Respir. Dis. -1993. -Vol. 148. -P. 14711478.

308. Holgate S. Is asthma an inflammatory disease//Eur. Respir. Dis. -1994. -Vol. 4. -Review 24.-P. 388-390.

309. Holgate S.T. Mediators and cytokine mechanisms in asthma//Thorax. -1993. -Vol. 48. -P. 103-109.

310. Holtzman M.J. Arachidonic acid metabolism//Am. Rev. Respir. Dis. -1991. -Vol. 143. -P. 188-203.

311. Honda Y., Kuroki Y., Matsuura E. et al. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids/Mm. J. Respir. Crit. Care Med. -1995. -Vol. 152. -P. 1860-1866.

312. Hone S.W., Donnelly M.J., Robertson J. et al. Dysphonia and inhalation of corticoids: a prospective study//Rev. Laryngol. Otol. Rhinol. Bord. -1996. -Vol. 117. -№4. -P.331-333.

313. Hong S.L., Levine L. Inhibition of arachidonic acid release from cells as the biochemical action of anti-inflammatory corticosteroids//Proc. Natl. Acad. Sci. USA -1976. -Vol.73. -P. 1730-1734.

314. Honour J.W., Kelnsr C.J.H., Brook C.G.D. Urine steroid excretion rates in childhood reflect growth and activity of adrenal cortex//Acta Endocrinol. -1990. -Vol. 14. -P. 219-224.

315. Hopp R.J., Degan J.A., Biven R.E. et al. Longitudinal assessment of bone mineral density in children with chronic asthma//Ann. Allergy Asthma Immunol. -1995. -Vol. 75. -P. 143-148.

316. Horn C.R., Clark T.J., Cochrane G.M. Inhaled therapy reduces morning dips in asthma/ZLancet. -1984. -Vol. 1. -P. 1143-1145.

317. Horwath J., Huszr E., Barath E. et al. Nitric oxide synthase inhibitors influence pulmonary cGMP levels in the guinea pig//Eur. Respir. J (Abstr. ERS Ann. Congrs.). -1996. -№0183. -P. 13-14.

318. Hoshino M., Nakamura Y. Anti-inflammatory effects of inhaled beclomethasone dipropionate in nonatopic asthmatics//Eur, Respir. J. -1996 Apr. -Vol. 9. -№4. -P. 696-702.

319. Hoshino M., Sim J., Shimizu K. et al. Effect of AA-2414, a thromboxane A2 receptor antagonist, on airway inflammation in subjects with asthma//! Allergy Clin. Immunol. -1999 Jun. -Vol. 103. -№6. -P. 1054-1061.

320. Howarth P. The airway inflammatory response in allergic asthma & its relationship to clinical disease//AHergy. -1995. -Vol. 50. -Suppl. 27. -P. 13-21.

321. Huang J., Olivenstein R., Taha R. et al. Enhanced proteoglycan deposition in the airway wall of atopic asthmatics//Am. J. Respir. Crit. Care Med. -1999 Aug. -Vol.160. -№2. -P. 725-729.

322. Hudon C., Turcotte H., Laviolette M. et al. Characteristics of bronchial asthma with incomplete reversibility of airflow obstruction//Ann. Allergy Asthma Immunol. -1997 Feb. -Vol. 78. -№2. -P. 195-202.

323. Ikuta N., Kondoh Y., Tangiguchi H. et al. Effect of long-term treatment with an inhaled corticosteroids on bronchial hyper-responsiveness and clinical asthma in asthmatic subjects/'/Arerugi. -1996 Dec. -Vol. 45. -№12. -P. 1231-1236.

324. Imai Т., Adachi M. Inhaled corticosteroid therapy in long-term management of adult asthma//Nippon-Rinsho. -1996 Nov. -Vol. 54. -№11. -P. 2969-2975.

325. Ip M., Lam K., Yam L. et al Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroid//Chest. -1994. -Vol. 105. -P. 17221727.

326. Ishihara K., Hasegawa Т., Nishimura T. et al. Increased use of inhaled corticosteroids and reduced hospitalizations in adult asthmatics: 11 years' experience in Japanese hospital/ZRespirology. -1998 Sep. -Vol. 3. -№3. -P. 193-7.

327. Ishioka S., Haruta Y., Hozawa S. et al. Effect of Leukotriene receptor antagonist, ONO-1078, on serum eosinophil cationic protein in patients with bronchial asthma//Allergy and Asthma. -1996. -Vol. 16. -№5. -P. 50.

328. Jackson L.D., Polygenis D., Mclvor R.A. et al. Comparative efficacy and safety of inhaled corticosteroids in asthma//Can. J. Clin. Pharmacol. -1999. -Vol. 6. -№1. -P. 2637.

329. Jaffiiel D., Mathieu M., Torado-de-la-Fuente P. et al. Corticoid therapy and bronchial inflammation in asthma. The use of bronchial biopsy//Rev. Mai. Respir. -1998 Jun. -Vol. 15. -№3. -P. 225-238.

330. Jain В., Lubinstein I., Robbins F.A. et al. Modulation of airway epithelial cell ciliary beat frequency by nitric oxide//Biochem. Biophys. Res. Commun. -1993. -Vol. 191. -P. 83-88.

331. Jang A.S., Choi I.S. Nitric oxide metabolites in patients with asthma: induced sputum versus blood/ZRespir. Med. -1999 Dec. -Vol. 93. -№12. -P. 912-918.

332. Jarvis В., Faulds D. Inhaled fluticasone propionate: a review of its therapeutic efficacy at dasages < or = 500 microg/day in adults and adolescents with mild to moderate asthma/ZDrugs. -1999 May. -Vol. 57. -№5. -P. 769-803.

333. Jatakanon A., Kharitonov S., Lim S. et al. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma//Thorax. -1999 Feb. -Vol. 54. -№2. -P. 108-114.

334. Jatakanon A., Lim S., Chung K.F. et al. An inhaled steroid improves markers of airway inflammation in patients with mild asthma//Eur. Respir. J. -1998 Nov. -Vol. 12. -№5. -P. 1084-1088.

335. Jeflfery P.K., Godfrey W., Adelroth. et al. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma//Am. Rev. Respir. Dis. -1992. -Vol. 145. -P. 890-899.

336. Joos G.F., Germonpre P.R., Pauwels R.A. Neural mechanisms in asthma//Clin. Exp. Allergy. -2000 Jun. -Vol. 30. -Suppl. 1. -P. 60-65.

337. Kacmarek R.M., Ripple R., Cockrill B.A. et al. Inhaled nitric oxide. A bronchodilatator in mild asthmatics with methacholine-induced bronchospasm//Am. J. Respir. Crit. Care Med. -1996 Jan. -Vol. 153. -№1. -P. 128-135.

338. Kaminsky D.A, Mitchell J., Carroll N. et al. Nitrotyrosine formation in the airways and lung parenchyma of patients with asthma//J. Allergy Clin. Immunol. -1999 Oct. Vol. 104. -№4 (Ptl). -P. 747-754.

339. Kanazawa H., Shoji S., Yoshikawa T. et al. Increased production of endogenous nitric oxide in patients with bronchial asthma and chronic obstructive pulmonary disease//Clin. Exp. Allergy. -1998 Oct. -Vol. 28. -№10. -P. 1244-1250.

340. Karim A.K., Jacob T.J., Thompson G.M. The human lens epithelium: morphological and ultrastructural changes associated with steroid therapy//Exp. Eye Res. -1989. -Vol. 48. -P. 215-224.

341. Kathleen J. Haley, Jeffrey M. Drazen. Inflammation and airway function in asthma. What You see is not necessarily what You get//Am. J. Respir. Crit. Care Med. -1998. -Vol. 157. -P. 1-3.

342. Kay A. Asthma & inflammation//J. Allergy Clin. Immunol. -1991. -Vol. 87. -P. 893-910.

343. Kelly C., Ward C., Stenton C. Numbers & activity of inflammatory cells in BAL fluid in asthma & their relation in airway responsiveness//Thorax. -1998. -Vol. 43. -P. 68492.

344. Kelso T.M., Abou-Shala N., Heilker G.M. et al. Comprehensive long-term management program for asthma: effect on outcomes in adult African-Americans//Am. J. Med. Sci. -1996 Jun. -Vol. 311. -№6. -P. 272-280.

345. Kerby J., Hargreave F., Gleich G et al. Bal cell profiles of asthmatic & nonasthmatic subjects//Amer. Rev. Respir. Dis. -1987. -Vol. 136. -P. 379-383.

346. Kerrebijn K.F., van Ess Zandvliet E.M., Neijens H.J. et al Effects of long-term treatment with inhaled corticosteroids and p2-agonists on the bronchial responsiveness in children with asthma//J. Allergy Clin. Immunol. -1987. -Vol.79. -P. 653-569.

347. Kharitonov S.A., O'Connor B.J., Evans D.J. et al. Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide//Am. J. Respir. Crit. Care Med. -1995. -Vol. 151. -P. 1894-1899.

348. Kharitonov S.A., Yates D., Robbins R.A. et al. Increased nitric oxide in exhaled air of asthmatic patients//Lancet. -1994. -Vol. 343. -P. 133-135.

349. Kirby J. G., Hargreave F.E., Gleich G.J. et al. Bronchoalveolar cell profiles asthmatic and nonasthmatic subjects//Am. Rev. Respir. Dis. -1997. -Vol. 136. -P. 379-383.

350. Kirsten A.M., Jorres R.A., Kirsten D. et al. Comparison of nasal and bronchial production of nitric oxide in healthy probands and patients with asthma/ZPneumologie. -1997 Apr. -Vol. 51. -№4. -P. 359-364.

351. Kitamura S., Hiwada K., Kobayashi J. et al. Use of the ED046 kit to analyze serum KL-6 in patients with pneumonitis//Nihon Kyoby Shikkan Gakkai Zasshi. -1996 Jun. -Vol. 34. -№6. -P. 639-645.

352. Kitamura S., Sugama Y. The management of chronic asthma with inhaled beta 2 agonists regular use? symptomatic use?//Nippon-Rinsho. -1996 Nov. -Vol. 54. -№11. -P. 3078-3080.

353. Kleerup E.C. Bronchodilators: new drugs and controversies//Curr. Opin. Pulm. Med. -1997 Jan. -Vol.3. -№1. -P. 17-22.

354. Klickstein L.B., Shapleigh C., Goetzl E.J. Lypoxygenation of arachidonic acid as a source of PMN leukocyte chemotactic factors in sinovial fluid and tissue in rheumatoid arthritis and spondiloarthritis//J. Clin. Invest. -1980. -Vol. 66. -P. 1166-1170.

355. Kobayashi J., Kitamura S. How can we monitor and treat patients with acute exacerbations of idiopathic interstitial pneumonia/ZNihon Kyoby Shikkan Gakkai Zasshi. -1996 Dec.-Suppl. 34.-P. 195-199.

356. Kobayashi J., Kitamura S. KL-6: a serum marker for intersitial pneumonia//Chest. -1995.-Vol. 108.-P. 311-315.

357. Kobayashi J., Kitamura S. Serum KL-6 for the evaluation of active pneumonitis in pulmonary sarcoidosis//Chest. -1996 May. -Vol. 109. -№5. -P. 1276-1282.

358. Kobayashi J., Tsukagoshi M., Hagiwara S. et al. Hypersensitivity pneumonitis monitored with serum KL-6, a marker of interstitial pneumonia//Nihon Kyoby Shikkan Gakkai Zasshi. -1996 Jul. -Vol. 34. -№7. -P. 837-842.

359. Kohno N. Clinical usefulness of KL-6 as a serum marker of idiopathic interstitial pneumonia//Nihon Kyoby Shikkan Gakkai Zasshi. -1996 Dec. -Suppl. 34. -P. 186-189.

360. Kohno N., Awaya Y., Oyama T. et al. KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease//Am. Rev. Respir. Dis. -1993 Sep. -Vol. 148. №3. -P. 637-642.

361. Kohno N., Kyoizumi S., Awaya Y. et al. New serum indicator of intersitial pneumonitis activity: sialyated carbohydrate antigen KL-6//Ibid. -1989. -Vol. 96. -P. 68-73.

362. Kolaczkowska M., Mlynarczyk W., Rzymkowska M. Long-term corticosteroid therapy as a risk factor of osteoporosis in patients with asthma and chronic bronchitisZZPneumonol. Alergol. Pol. -1996. -Vol. 64. -№3-4. -P. 196-203.388.

363. Konig P. Evidence for benefits of early intervention with non-steroidal drugs in asthmaZZPediatr. Pulmonol. -1997. -Suppl. 15. -P. 34-39.

364. Konig P., Shaffer J. The effect of drug therapy on long-term outcome of childhood asthma: a possible preview of the international guidelines//!. Allergy Clin. Immunol. -1996 Dec. -Vol. 98. -№6(Ptl). -P. 1103-1111.

365. Kraft M., Wenzel S.E., Bettinger C.M. et al. The effect of salmeterol on nocturnal symptoms, airway function, and inflammation in asthma//Chest. -1997 may. -Vol. 111. -№5. -P. 1249-1254.

366. Kudo K. High dose inhaled steroid therapy usefulness and limitationZZNippon-Rinsho. -1996 Nov. - Vol. 54. -№11. -P. 2993-2997.

367. Kuitert L.M., Newton R., Barnes N.C. et al. Eicosanoid mediator expression in mononuclear and polymorphonuclear cells in normal subjects and patients with atopic asthma and cystic fibrosis/ZThorax. -1996 Dec. -Vol. 51. -№12. -P. 1223-1228.

368. Kumar A., Busse W.W. Clinical aspects of anti-inflammatory therapy in asthmaZZCurr. Opin. Pulm. Med. -1996 Jan. -Vol. 2. -№1. -P. 40-47.

369. Laitinen A., Altraja A., Kampe M. et al. Tenascin is increased in airway basement membrane of asthmatics and decreased by inhaled steroid//Am. J. Respir. Crit. Care Med. -Vol. 1997 Sep. -Vol. 156. -№3 (Ptl). -P. 951-958.

370. Laitinen L., Laitinen A. Structural & cellular changes in asthma//Eur. Respir. Rev. -1994. -Vol. 4. P. 348-351.

371. Laitinen L., Laitinen A. Structural & cellular changes/ZEpithelial pathology in asthma a target for drug therapyZZAstra satellite symposium at the 3 ERS Congress, Firenze, September 26. -1993. -P. 4-5.

372. Laitinen L., Laitinen A., Haahtata T. Airway mucosa inflammation even in patients with newly diagnosed asthmaZZAm. Rev. Respir. Dis. -1993. -Vol. 147. -P. 697704.

373. Lam S., Le Riche J., Phillips D. et al. Cellular & protein changes in bronchoalveolar lavage fluid after late asthmatic reactions in patients with red cedar asthma//J. Allergy Clin. Immunol. -1987. -Vol. 80. -P. 44-50.

374. Lane S. J., Lee Т.Н. Cellular and molecular mechanisms of glucocorticoid-resistant asthma//Atemwegs-und Lungenkrankh. -1997. -Vol. 23. -№7. -P. 362.

375. Larsen B.B., Dahl R. Do inhaled steroids have similar efficacy? A case of bronchial asthma suggesting different efficacy of inhaled glucocorticosteroids//Allergy. -1995 Jul. -Vol. 50. -№7. -P. 600-603.

376. Le Merre C., Bengtsson Т., Bretecher P. et al. Effect on lung function and inflammatory markers of single-doses of inhaled budesonide in asthmatics//Allergy and Asthma. -1996. -Vol. 16. -№5. -P. 54.

377. Ledford D., Apter A., Brenner A.M. et al. Osteoporosis in the corticosteroid-treated patients with asthma//J. Allergy Clin. Immunol. -1998. -Vol. 102. -№3. -P. 353-362.

378. Leikauf G.D., Driscoll K.E., Wey H.E. Ozone-induced augmentation of eicosanoid metabolism in epithelial cells from bovine trachea//Am. Rev. Respir. Dis. -1988. -Vol. 137. -P. 435-442.

379. Levy J. Effect of prolonged use of inhaled steroids on the cellular immunity of children with asthma//J. Allergy Clin. Immunol. -1995. -Vol. 95. -P. 806-812.

380. Levy J., Zalkinder I., Kuperman O. et al. Effect of prolonged use of inhaled steroid in the cellular immunity of children with asthma//Ibid. -1996. -Vol. 95. -№4. -P. 806-812.

381. Levy M.L., Stevenson C., Maslen T. Comparison of short courses of oral prednosolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care//Thorax. -1996 Nov. -Vol. 51. -№11. -P. 1087-1092.

382. Lewis R.A., Austen K.F. Molecular determinants for functional responses to the sulfidopeptide leukotrienes: metabolism and receptor subclasses//! Allergy Clin. Immunol. -1984. -Vol. 74. -P. 369-373.

383. Lonnebo A., Grahnen A., Jansson B. et al. An assessment of the systemic effects of single and repeated doses of inhaled fluticasone propionate and inhaled budesonide in healthy volunteers//Eur. J. Clin. Pharmacol. -1996. -Vol. 49. -№6. -P. 459-463.

384. Lonnebo A., Grahnen A., Ling-Andersson A. et al. A comparison of the effects on the HPA-axis of single and repeated doses of inhaled fluticasone propionate and BUD//Am. J. Respir. Crit. Care Med. -1995. -Vol. 151. -№4 (Pt2). -P. 375.

385. Lou Y.P., Takeyama К., Grattan K.M. et al. Platelet-activating factor induces goblet cell hyperplasia and mucin gene expression in airways//Am. J. Respir. Crit. Care Med. -1998 Jun. -Vol. 157. -№6 (Ptl). -P. 1927-1934.

386. Luengo M., Picado C., Piera C. et al. Intestinal calcium absorbtion & parathyroid hormone secretion in asthmatic patients on prolonged oral or inhaled steroid treatment//Eur. Respir. J. -1991. -Vol. 4. -№4. -P. 441-444.

387. Mac Donald B.R., Gowen M. Cytokines & bone//Brit. J. Rheumatol. -1992. -Vol. 31. -№2. -P. 149-155.

388. Mackenzie C.A., Wales J.K.H. Knemometry and its practical application//Eur. Respir. J. -1993. -Vol. 3. -№13. -P. 321-325.

389. Mackie AE., Ventresca G.P., Moss J.A. et al. Pharmacokinetics of intravenous fluticasone propionate in healthy subjects//Br. J. Clin. Pharmacol. -1995. -Vol. 40. -P. 198.

390. Madden V. Asthma: how early to start using inhaled steroids?//Prof. Care Mother Child. -1887. -Vol. 7. -№1. -P. 21-22.

391. Malo J.L., Carrier A., Cote J. et al. Influence of inhaled steroids on recovery from occupational asthma after cessation of exposure: a 18-month double-blind crossover study//Am. J Respir. Crit. Care Med. -1996 Mar. -Vol. 153. -№3. -P. 953-960.

392. Mansour M., Farouk N., el-Maragy A. et al. Elevated plasma level of leukotrienes in bronchial asthma patients; a possible clinical relevance//Dis. Markers. -1995 Mar. -Vol. 12. -№2. -P. 117-122.

393. Maria G., Bellofiore S., Ciancio N. et al. Platelet activating factor increases airway reactivity but not maximal bronchoconstriction to methacholine in normal subjects//Europ. Respir. J. -1993. -Vol. 6. -S. 17. -P. 0854.

394. Marom Z., Shelhamer J.H., Bach M.K. et al. Slow reacting substances, LTC4 and D4 increase the release of mucus from human airway in vitro//Am. Rev. Respir. Dis. -1982. -Vol. 126. -P. 449-451.

395. Martin T.R., Ranji G., Merrit T.L. et al. Relactive contribution of LTB4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophages//!. Clin. Invest. -1987. -Vol. 80. -P. 1114-1129.

396. Martinati L.C., Bertoldo F., Gasperi E. et al. Effect on cortical and trabecular bone mass of different anti-inflammatory treatments in preadolescent children with chronic asthma//Am. J. Respir. Crit. Care Med. -1996. -Vol. 153. -№1. -P. 232-236.

397. Martinez F.D. Present and future treatment of asthma in infants and young children//! Allergy. Clin. Immunol. -1999 Oct. -Vol. 104. -№4 (Pt2). -P. 169-174.

398. MasGlashan D., Schleimer R.P., peters S.P. Generation of leukotrienes by purified human lung mast cells//! Clin. Invest. -1982. -Vol.70. -P. 747-751.

399. Massaro A.F., Gaston В., Kita D. et al. Expired nitric oxide levels during treatment of acute asthma//Am. J. Respir. Crit. Care Med. -1995 Aug. -Vol. 152. -№2. -P. 800-803.

400. Matsumoto K., Taki F., Miura M. et al. Serum levels of soluble IL-2R, IL-4 & soluble Fc ER П in adult bronchial asthma//Chest. -1994. -Vol. 105. -P. 681-686.

401. Mattes J., Storm-van's-Gravesande K., reining U. et al. NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma//Eur. Respir. J. -1999 Jun. -Vol. 13. -№6. -P. 1391-1395.

402. Mautino G., Henriquet C.n Gougat C. et al. Increased expression of tissue inhibitor of metalloproteinase-1 and loss of correlation with matrix metalloproteibase-9 by macrophages in asthma//Lab-Invest. -1999 Jan. -Vol. 79. -№1. -P. 39-47.

403. Mc Leod J.F. Osteoporosis, cytokines & glucocorticoids//Allergy Proc. -1993. -Vol. 14. -№5. -P. 363-364.

404. McFadden E.R. Inhaled glucocorticoids and acute asthma: therapeutic breakthrough or nonspecific effect?//Am. J. Respir. Crit. Care Med. -1998 Mar. -Vol. 157. -№3 (Ptl). -P. 698-703.

405. Meltzer E.O., Kemp J.P., Orgel H.A. et al. Flunisolide aerosol for treatment of severe, chronic asthma in steroid-independent children/ZPediatrics. -1982. -Vol. 69. -P. 340.

406. Messer J.W., Peters G.A., Bennet W.A. et al. Causes of death & pathologic findings in 304 cases of bronchial asthma//Dis. Chest. -1960. -Vol. 38. -P. 612-24.

407. Metzger W., Zavala D., Richerson H. et al. Local allergic challenge & bronchoalveolar lavage in allergic asthmatic lungs: description of the model & local allergic inflammation//Am. Rev. Respir. Dis. -1987. -Vol. 135. -P. 433-440.

408. Michael Y. Viksman, Mark C. Liu, Carol A. Bickel et al. Phenotypic analysis of alveolar macrophages and monocytes in allergic airway inflammation//Am. J. Respir. Crit. Care Med. -1997. -Vol. 166. -P. 858-863.

409. Michel F.B., Chanez P. Asthma and corticosteroid therapy//Presse-Med. -1996 Mar. -Vol. 25. -№9. -P. 436-437.

410. Milanowski J., Qualtrough J., Perrin V.L. Inhaled beclomathasone (BDP) with non-CFC propellant (HFA 134a) is equivalent to BDP-CFC for the treatment of asthma//Respir. Med. -1999 Apr. -Vol. 93. -№4. -P. 245-251.

411. Mita H., Yui Y., Taniguchi N. et al. Increased activity of 5-lipoxygenase in PMN leukocytes from asthmatic patients//Life Sci. -1985. -Vol. 37. -P. 907-914.

412. Mitsunobu F., Mifiine Т., Hosaki Y. et al. Different roles of histamine and leukotriene C4 in the airways between patients with atopic ana nonatopic asthma//! Asthma. -1998. -Vol. 35. -№4. -P. 367-372.

413. Moreno R.H., Hogg J.C., Pare P.D. Mechanics of airway narrowing//Am. Rev. Respir. Dis.-1985.-Vol. 133 -P. 1171-1180.

414. Nagai H., Tanaka I; fhe role of cytokines and arachidonic acid metabolites in the development of airway hyperresposiveness//Nippon-Yakurigaku-Zasshi. -1998 Apr. -Vol. 111.-№4.-P. 233-41.

415. Nasser S.M., Pfister R., Christie P.E et al. Inflammatory cell population in bronchial biopsies from aspirin-sensitive asthmatic subjects//Am. J. Respir. Crit. Care Med. -1996 Jan. -Vol. 153. -№1. -P. 90-96.

416. Nassif E., Weinberger M., Sherman B. et al. Extrapulmonary effects of maintenance corticosteroid therapy with alternate-day prednisone and inhaled beclomethasone in children with chronic asthma//J. Allergy Clin. Immunol. -1987. -Vol. 80. -P.518-529.

417. Nathan R.A, Pinnas J.L., Schwartz H.J. et al. A six-month, placebo-controlled comparison of the safety and efficacy of salmeterol or beclomethasone for persistent asthma//Ann. Allergy Asthma Immunol. -1999 Jun. -Vol.82. -№6. -P. 521-529.

418. Nelson B.V., Sears S., Woods J. et al. Expired nitric oxide as a marker for childhood asthma//! Pediatr. -1997 Mar. -Vol. 130. -№3. -P. 423-427.

419. Nelson H.S. New developments in bronchodilator therapy//Curr. Opin. Pulm. Med. -1996 Jan. -Vol. 2. -№1. -P. 35-39.

420. Nikolaizik W.H., Preece M.A., Warner J.O. One year follow-up study of endocrine and lung function of asthmatic children on inhaled budesonide//Eur. Respir. J. -1997 Nov. -Vol. 10. -№11. -P. 2596-2601.

421. Ninan Т.К., Russel G. Asthma, inhaled corticostetoids treatment, and growth//Arch. Dis. Child. -1992. -Vol. 67. -№6. -P. 703-705.

422. O'Byrne P. What's new in mediators & mediator antagonists?//Eur. Respir. Rev. -1994. -Vol. 4. -Review 24. -P. 399-401.

423. O'Sullivan S. On the role of PGD2 metabolites as markers of mast cell activation in asthma//Acta Physiol. Scand. Suppl. -1999 Apr. -Vol. 644. -P. 1-74.

424. Ollerenshaw S.L., Woelcock A.J., Characteristics of the inflammation in biopsies from large airways of subjects with asthma and subjects with chronic airflow inflammation//Am. Rev. Respir. Dis. -1S92. -Vol. 145. -P. 922-927.

425. Orsida B.E., Li X., Hickey B. et al. Vascularity in asthmatic airways: relation to inhaled steroid dose//Thorax. -1999 Apr. -Vol. 54. -№4. -P. 289-295.

426. Oyama Т., Kohno N., Yokoyama A. et al. Detection of interstitial pneumonitis in patients with rheumatoid arthritis by measuring circulating levels of KL-6, a human MUC1 mucin//Lung. -1997. -Vol. 175. -№6. -P. 379-385.

427. Park С., Lee S., Sung Wham Chung et al. Interleukin-2 & soluble interleukin-2 receptors in bronchoalveolar lavage fluid patients with bronchial asthma//Chest. -1994. -Vol. 106. -P. 400-6.

428. Paterson J.W., Lulich K.M., Goldie R.G. Pharmacology of asthma treatment: an overview//Med. J. Aust. -1995. -Vol. 162. -№1. -P. 42-43.

429. Pauwels R. Asthma-managing the underlying disease//Eur respir rev. -1994.-№4 (review 21). -P. 291-4.

430. Pedersen В., Dahl R., Karlstrom R. et al. Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking//Am. J. Respir. Crit. Care Med. -1996 May. -Vol. 153. -№5. -P. 1519-1529.

431. Pedersen S., O'Byrne P. A comparison of the efficacy and safety of inhaled corticosteroids in asthma//Allergy. -1997. -Vol. 52. -Suppl. 39. -P. 1-34.

432. Pedersen S., Szefler S. Pharmacological interventions. Childhood asthma//Eur. Respir. J. Suppl. -199S Jul. -Vol. 27. -P. 40-45.

433. Peters S. Mast cells & histamine in asthma//! Allergy Clin. Immunol. -1990. -Vol. 86. -P. 642-646.

434. Petersen W., Karup-Pedersen F., Friis В et al. Sodium cromoglycate as a replacement for inhaled corticosteroids in mild-to-moderate childhood asthma//Allergy. -1996 Dec. -Vol. 51. -№12. -P. 870-875.

435. Petty T. L. Early identification and intervention in chronic obstructive pulmonary disease//Lung respir. -1993. -Vol. 10. -P. 2-3.

436. PfefFer K.D., Ellison G., Robertson D. et al. The effect of inhaled nitric oxide in pediatric asthma//Am. J. Respir. Crit. Care Med. -1996 Feb. -Vol. 153. -№2. -P. 747-751.

437. Phillipps G.H. Structure-activity relationships of topically active steroids: the selection of fluticasone propionate//Respir. Med. -1990. -Vol. 84. -Suppl. A. -P. 19-23.

438. Picado C., Deulofeu R., Lleonart R. et al. Lipid and protein metabolism in asthma. Effects of diet and corticosteroid therapy//Allergy. -1999 Jun. -Vol. 54. -№6. -P. 569-575.

439. Pieters W.R., Steinmetz K.O., Aubier M. et al. Effectiveness of a new salmeterol/ fluticasone propionate (50/250mcg) combination inhaler in patients with reversible airways obstruction//Eur. Respir. J. -1998. -Vol.12, Suppl. 28. -P. 35s.

440. Pincus D.J., Szefler S.J., Ackerson L.M. et al. Chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy//! Allergy Clin. Immunol. -1995 Jun. -Vol. 95. -№6. -P. 1172-1178.

441. Piper P.J. Pharmacology of leukotrienes//Br. Med. Bull. -1983. -Vol. 39. -№3. -P. 255-259.

442. Pirozynski M., Kulaga Z., Kalstrom R. Pulmicort (Budesonide) Turbuhaler in mild to moderate asthma//Allergy and Asthma. -1995. -Vol. 16. -№5. -P. 14.

443. Polak J.M., Holgate S.T., Howarth P.H. Airway endothelin levels in asthma: influence of endobronchial allergen challenge and maintenance corticosteroid therapy//Eur. Respir. J. -1997 May. -Vol. 10. -№5. -P. 1026-1032.

444. Ponticiello A., Vatrella A., Parrella R. et al. Inhaled beclomethasone dipropionate (BDP) prevents seasonal changes in atopic asthmatics//Monaldi Arch. Chest Dis. -1997 Apr. -Vol. 52. -№2. -P. 112-117.

445. Poston R.N., Chanez P., Lacoste J.Y. et al. Immunohistochemical characterization of the cellular infiltration in asthmatic bronchi//Am. Rev. Respir. Dis. -1992. -Vol. 145. -P. 918-921.

446. Preice J.F. Inhaled corticosteroids: clinical relevance of safety measures/ZPediatr. Pulmonol. -1997. -Suppl. 15. -P. 40-45.

447. Preice J.F., Russel G., Hindmarsh P. et al. Growth velocity in asthmatic children receiving fluticasone propionate 50 meg bd or sodium cromoglycate 20 mg qds//Eur. Respir. J. -1996. -Vol. 9. -Suppl. 23. -P. 294.

448. Rajah R., Nachajon R.V., Collins M.K. et al. Elevated levels of the IGF-binding protein protease MMP-1 in asthmatic airway smooth muscle//Am. J. Respir. Cell Mol. Biol. -1999 Feb. -Vol. 20. -№2. -P. 199-208.

449. Rao R., Gregson R.K., Frederick J.M. et al. Eosinophil markers show changes before improvement in lung function parameters in atopic children with asthma, when treated with inhaled steroids//Allergy & Asthma. -1996. -Vol. 16. -№5. -P. 24.

450. Raychaudhuri В., Dweik R., Connors M.J. et al. Nitric oxide blocks factor-kappaB activation in alveolar macrophages//Am. J. Respir. Cell Mol. Biol. -1999 Sep. -Vol. 21.-№3. P.-311-316.

451. Redington A.E. Springall D R., Ghatei M.A. et al. Airway endothelin levels in asthma: influence of endobronchial allergen challenge and maintenance corticosteroid therapy//Eur. Respir. J. -1997 May. -Vol. 10. -№5. -P. 1026-1032.

452. Redington A.E., Springall D.R., Meng Q.H. et al. Immunoreactive endothelin in bronchial biopsy specimens: increased expression in asthma and modulation by corticosteroid therapy//! Allergy Clin. Immunol. -1997 Oct. -Vol. 100. -№4. -P. 544-552.

453. Reeves J.T., Stenmark K.R., Voelkel N.F. Possible role of leukotrienes in pathogenesis of pulmonary hypertensive disorders//The Pulmonary circulation and acute lung injury/Ed. S. I. Said. -Mount Kisco: Futura Publ., 1985. p. 337-356.

454. Restrick L.J., Sampson A.P., Piper P.J. et al. Reduction in leukotriene B4 generation by bronchoalveolar lavage cells in asthma//Thorax. -1995 Jan. -Vol. 50. -№1. -P. 67-73.

455. Ricciardolo F.L., Geppetti P., Mistretta A. et al. Randomised double-blind placebo-controlled study of the effect of nitric oxide synthesis in bradykinin-induced asthma/ZLancet. -1996 Aug. -Vol. 348. -№9024. -P. 374-377.

456. Richman-Eisenstal J., Jorens J., Hebert C. et al. Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases//Am. J. Physiol. -1993. -Vol. 264. -P. 413-418.

457. Riise G.C., Andersson В., Ahlstedt S. et al. Bronchial brush biopsies for studies of epithelial inflammation in stable asthma and nonobstructive chronic bronchitis//Eur. Respir. J. -1996 Aug. -Vol. 9. -№8. -P. 1665-1671.

458. Robbins R.A., Barnes P.J., Springall D.R. et al. Expression of inducible nitric oxide synthase in human bronchial epithelial cells//Biochem. Biophys. Res. Commun. -1994. -Vol. 203. -P. 209-218.

459. Robinson C.B., Martin W.R., RatlifF J.L. et al. Elevated levels of serum mucin-associated antigen in adult patients with cystic fibrosis//Am. Rev. Respir. Dis. -1993 Aug. -Vol.148. -№2. -P. 385-389.

460. Rohdewald P., von Eiff M., Wurthwein G. Activation of beclomethasone dipropionate in bronchial secretion and receptor affinities and solubility of inhalative applied glucocorticoids//Atemwegs-Lungenkrankh. -1990. -Vol. 16. -P. 79-84.

461. Rohdewald P.J. Comparison of clinical efficacy of inhaled glucocorticoids//Arzneimittelforschung. -1998 Aug. -Vol. 48. -№8. -P. 789-796.

462. Romain A., Pauwels., Claes-Goran Lofdahl et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma//New Engl. J. Med. -1997. -Vol. 337. -№20. -P. 1405-1411.

463. Rosenthal R.R., Busse W.W., Kemp J.P. et al. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness//Chest. -1999 Sep. -Vol. 116. -№3. -P. 595-602.

464. Rossi G.A., Crimi E., Lantero S. et al. The late-phase asthmatic reaction to inhaled allergen is associated with early recruitment of eosinophils in the airways//Am. Rev. Respir. Dis. -1991. -Vol. 143. -P. 379-83.

465. Ruegsegger P., Medici T.C., Anliker M.//Eur. J. Clin. Pharmacol. -1983. -Vol.25. -P. 615-620.

466. Russell G., Williams D.A., Weller P. et al. Salmeterol xinafoate in children on high dose inhaled steroids//Ann. Allergy Asthma Immunol. -1995 Nov. -Vol. 75. -№5. -P. 423-428.

467. Ryrfeldt A., Andersson P., Edsbacker S. et al. Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid//Eur. J. Respir. Dis. -1982. -Vol. 63. -Suppl. 122. -P. 86-95.

468. Sabbah A. General considerations on asthma'/Allerg. Immunol. Paris. -1996 Sep. -Vol. 28. -№7. -P. 242-245.

469. Saetta M., Di Stephano A., Rosina C. et al. Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma//Am. Rev. Respir. Dis. -1991. -Vol. 143. -P. 138-143.

470. Samhoun M.N., Piper P.J. Actions and interactions of lipoxygenase and cyclooxygenase producte in respiratory and vascular tissue//Prostagland. Leukotr. Med. -1984. -Vol.13. -№1. -P. -79-87.

471. Sampson A.P., Castling D.P., Green C.P. et al. Persistent increase in plasma and urinary leukotrienes after acute asthma//Acta Dis. Child. -1995 Sep. -Vol. 73. -№3. -P. 221225.

472. Sanders S.P. Asthma, viruses, and nitric oxide//Proc. Soc. Exp. Biol. Med. -1999 Mar. -Vol. 220. -№3. -P. 123-132.

473. Sane A.C., Mendemhall Т., Bass D.A. Secretory phospholipase A2 activity is elevated in bronchoalveolar lavage fluid after ovalbumin sensitization of guinea pigs//J. Leukoc. Biol. -1996 Dec. -Vol. 60. -№6. -P. 704-709.

474. Sanjiv S., Crotty T.B., Kephart G.M. et al. Sudden-onset fatal asthma//Am. Rev. Respir. Dis. -1993. -Vol. 148. -P. 713-9.

475. Schafer D., Schamid M., Gode U.C. et al. Dynamics of eicosanoids in peripheral blood cells during bronchial provocation in aspirin-intolerant asthmatics//Eur. Respir. J. -1999 Mar. -Vol. 13. -№3. -P. 638-646.

476. Scher H., Berman D., Weinberg E.G. et al. Granulocyte proteins in serum in childhood asthma: relation to spirometry and therapy//Clin. Exp. Allergy. -1996 Oct. -Vol. 26.-№io.-P. 1131-1141.

477. Schuiling M., Meurs H., Zuidhof A.B. et al. Dual action of iNOS-derived nitric oxide in allergen-induced airway hyperreactivity in conscious, unrestrained guinea pigs//Am. J. Respir. Crit. Care Med. -1998 Nov. -Vol. 158. -№5 (Ptl). -P. -1442-1449.

478. Sekerel B.E., Tuncer A., Saraclar Y. et al. Inhaled budesonide reduces lung hyperinflation in children with asthma//Acta Paediatr. -1997 Sep. -Vol. 86. -№9. -P. 932936.

479. Serhan C.N., Hamberg M., Manuelsson B. Lipoxins. A novel series of compounds formed from arachidonic acid in human leukocytes//Proc. Natl. Acad. Sci. USA. -1984. -Vol. 91. -P. 5335-5339.

480. Serrano !, Plaza V., Sanchis J. Hospital admission for asthma. Descriptive analysis and prognostic factors after discharge//Arch. Bronconeumol. -1999 Sep. -Vol. 35. -№8. -P. 372-378.

481. Shamsuddin M., Chen E., Anderson J. et al. Regulation of leukotriene and platelet-activating factor synthesis in human alveolar macrophages//! Lab. Clin. Med. -1997 Dec. -Vol. 130. -№6. -P. 615-626.

482. Shapiro G., Bronsky E.A., LaForce C.F. et al. Dose-related efficacy of budesonide administrated via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma//! Pediatr. -1998 Jun. -Vol. 132. -№6. -P. 976-982.

483. Shaver J.R., Zangrilli J., cirelli K.A et al. Regular inhaled beta2-agonist treatment of allergic asthmatics causes loss of broncho-protection vs methacholine without altering inflammatory responses//Allergy and Asthma. -1995. -Vol. 16. -№5. -P. 17.

484. ShefFer A.L., LaForce C., Chervinsky P. et al. Fluticasone propionate aerosol: efficacy in patients with mild to moderate asthma. Fluticasone Propionate Asthma Study Group//! Fam. Pract. -1996 Apr. -Vol. 42. -№4. -P. 369-375.

485. Sherrington C.A., Mallol J. Early effects of inhaled steroids on airway hyperreactivity and pulmonary function in asthma//Pediatr-Pulmonol .-1999 Jun. -Vol. 27. -№6. -P. 376-382.

486. Shi H., Yokoyama A., Kohno N. et al. Effect of thromboxane A2 inhibitors on allergic pulmonary inflammation in mice//Eur. Respir. Dis. -1998 Mar. -Vol. 11. -№3. -P. 624-629.

487. Shindo K., Fukumura M., Miyakawa K. Leukotriene B4 levels in the arterial blood of asthmatic patients and the effects of prednisolone//Eur. Respir. Dis. -1995 Apr. -Vol. 8. -№4. -P. 605-610.

488. Shindo K., Koide K., Fukumura M. Enhancement of Leukotriene B4 release in stimulated asthmatic neutrophils by platelet activating factor//Thorax. -1997 Dec. -Vol. 52. -№12. -P. 1024-1029.

489. Shindo K., Koide K., Fukumura M. Platelet-activating factor increases Leukotriene B4 release in stimulated alveolar macrophages from asthmatic patients//Eur. Respir. J. -1998 May. -Vol. 11. -№5. -P. 1098-1104.

490. Simons F.E. Benefits and risks of inhaled glucocorticosteroids in children with persistent asthma//! Allergy Clin. Immunol. -1998 Nov. -Vol. 102. -№5. -P. 77-84.

491. Simons F.E. Inhaled glucocorticoids in children: A favourable therapeutic index//Can. Respir. J. -1999 Mar-Apr. -Vol. 6. -№2. -P. 175-178.

492. Simons F.E.R., Persaud M.P., Gillespie C.A. et al. Absence of posterior subcapsular cataracts in young patients treated with inhaled corticosteroids/ZLancet. -1993. -Vol. 342. -P. 776-778.

493. Skoner D.P. Risk/benefit ratio of inhaled steroids//! Pediatr. -1996. -Vol. 129. -№6. -P. 942.

494. Smeenk F.W., Klinkhamer P.J., Breed W. et al. Opportunistic lung infections in patients with chronic obstructive lung disease: a side effect of inhalation corticosteroids?//Ned. Tijdschr. Geneeskd. -1996 Jan. -Vol. 140. -№2. -P. 94-98.

495. Sont J.K., Han J., van-Krieken J.M. et al. Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids//Thorax. -1996 May. -Vol. 51. -№5. -P. 496-502.

496. Sorva R, Tahtela R., Turpeinen M. et al. Changes in bone markers in children with asthma during inhaled budesonide and nedocromil treatments//Acta Paediatr. Int. J. Paediatr. -1996. -Vol. 85. -№10. -P. 1176-1180.

497. Sousa A.R., Trigg C.J., Lane S.J. et al. Effect of inhaled glucocorticoids on IL-1 beta and IL-1 receptor antagonist (IL-1 ra) expression in asthmatic bronchial epithelium//Thorax. -1997 Mar. -Vol. 52. -№5. -P. 407-410.

498. Spahn J.D., Leung D.Y. The role of glucocorticoids in the management of asthma//Allergy Asthma Proc. -1996 Nov-Dec. -Vol. 17. -№6. -P. 341-350.

499. Spahn J.D., Leung D.Y., Szefler S.J. New insights into the pathogenesis and management of steroid-resistant asthma//J. Asthma. -1997. -Vol. 34. -№3. -P. 177-194.

500. Spencer C.M., Jarvis B. Salmeterol/fluticasone propionate combination// Drugs. 1999 Jun. -Vol. 57. -№6. -933-940.

501. Springall D.R., Meng Q., Redington A. et al. Inducible nitric oxide synthase in asthmatic airway epithelium is reduced by corticosteroid therapy//Am. J. Respir. Crit. Care Med. -1995. -Vol. 151. -P. 833.

502. Storr J., Berell E., Barry W. et al. Effect of single dose of prednisolone in acute childhood asthma//Lancet. -1997; ii. -P. 879-881.

503. Strausi J. Pathomorphology of the airways in asthma//Acta Microbiol. Immunol. Hung. -1998. -Vol.45. -№1. -P. 15-18.

504. Street M., Mossman T. Functional diversity of T-lymphocytes due to secretion of different cytokine pattern/ZFASEBJ. -1991. -Vol. 5. -P. 171-177.

505. Sugaya F., Tanaka H., Sekine k. et al. Neutrophil elastase: a 1 anti-protease inhibitor complex, eosinophil cationic protein and soluble IL-2-receptor in asthma exacerbation//Allergy and Asthma. -1996. -Vol. 16. -№5. -P. 45.

506. Svedmyr J., Nybery E., Asbrink-Nilsson E. et al. Intermittent treatment with inhaled steroids for deterioration of asthma due to upper respiratory tract infections//Acta Paediatr. -1995. -Vol. 84. -P. 884-888.

507. Sy M.L.T., Chin T.W., Nussbaum E. Pneumocystis carinii pneumonia associated with inhaled corticosteroids in an immunocompetent child with asthma//J. Pediatr. -1995. -Vol. 127. -P. 1000-1002.

508. Syrbu S., Thrall R.S., Smilowitz H.M. Sequential appearance of inflammatory mediators in rat bronchoalveolar lavage fluid after oleic acid-induced lung injury//Exp. Lung Res. -1996. -Vol. 22. -P. 33-49.

509. Szefler S.J. Early intervention for childhood asthma: inhaled glucocorticoids as the "preferred" medication//! Allergy Clin. Immunol. -1998 Nov. -Vol. 102. -№5. -P. 719721.

510. Szefler S.J., Boushey H.A., Pearlman D.S., Togias A. et al. Time to onset of effect of fluticasone propionate in patients with astnma//J. Allergy Clin. Immunol. -1999 May. -Vol. 103 (5 Pt 1). -P. 780-8.

511. Szefler S.J. Clinical need for a nebulized corticosteroid//J. Allergy Clin. Immunol. -1999 Oct. -Vol. 104. -№4 (Pt2). -P. 162-168.

512. Takahashi Т., Munakata M., Suzuki I. et al. Serum and bronchoalveolar fluid KL-6 levels in patients with pulmonary alveolar proteinosis//Am. J. Respir. Crit. Care Med. -1998 Oct. -Vol. 158. -№4. -P. 1294-1298.

513. Taylor D.A., McGrath J.L., Orr L.M. et al. Effect of endogenous nitric oxide inhibition on airway responsiveness to histamine and adenosine-5'-monophosphate in asthma//Thorax. -1998 Jun. -Vol. 53. -№>6. -P. 483-489.

514. Ten-Hacken N.H., Dosterhoff Y, Kauffman H.F. et al. Elevated serum interferon-gamma in atopic asthma correlates with increased airways responsiveness and circadian peak expiratory flow variation//Eur. Respir. J. -1998 Feb. -Vol. 11. -№2. -P. 312-6.

515. Terr A.I., Bloch D.A. Trends in asthma therapy in the United States: 1965-1992//Ann. Allergy Asthma Immunol. -1996 Mar. -Vol. 76. -№3. -P. 273-281.

516. Thomas B.C., Stanhope R., Grant D.B. Impairment growth in children with asthma during treatment with conventional doses of inhaled corticosteroids//Acta Paediatr. Int. J. Paediatr. -1994. -Vol. 83. -№2. -P. 196-199.

517. Thorsson L., Dahlstrom K., Edsbacker S. et al. Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects//Br. J. Clin. Pharmacol. -1997 Feb. -Vol. 43. -№2. -P. 155-161.

518. Thorsson L., Kallen A., Wiren J-E. et al. Pharmacokinetics of inhaled fluticasone propionate//Am. J. Respir. Crit. Care Med. -1996. -Vol. 153 (Suppl.). -№4 (Pt2). -P. 801.

519. Tinkelman D.G., Reed C.E., Nelson H.S. et al. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children/ZPediatrics. -1993. -Vol. 92. -P. 64-77.

520. Toogood J.H., Baskerville J.C., Jennings B. et al. Influence of dosing frequency & schedule on response of chronic asthmatics to the aerosol steroid budesonide//J. Allergy Clin. Immunol. -1992. -Vol. 72. -P. 288-298.

521. Toogood J., Crilly R, Jones G. et al. Effect of high-dose inhaled budesonide on calcium and phosphate metabolism and the risk of osteoporosis//Am. Rev. Respir. Dis. -1988.-Vol. 138.-P. 57-61.

522. Toogood J.H., Jennings В., Baskerville J. et al. Bronchial Asthma: Mechanisms and Therapeutics, -Eds. E. B. Weiss, M. Stein. -3-rd Ed. -Boston, 193. -818-841 p.

523. Toogood J.H., Markov A.E., Baskerville J. et al. Association of ocular cataracts with inhaled and oral steroid therapy during long-term treatment of asthma//J. Allergy Clin. Immunol. -1993. -Vol. 91. -P. 571-579.

524. Tormey V.J., Faul J., Leonard C. et al. A comparison of regular with intermittent bronchodilators in asthma patients on inhaled steroids/Яг. J. Med. Sci. -1997 Oct-Dec. -Vol. 166. -№4. -P. 249-252.

525. Trescoli C., Ward M.J. Systemic activity of inhaled and swallowed beclomethasone dipropionate and the effect of different inhaler devices/ZPostgrad. Med. J. -1998 Nov. -Vol. 74. -№877. -P. 675-677.

526. Ulrik C.S. Outcome of asthma: longitudinal changes in lung function//Eur. Respir. J. -1999 Apr. -Vol. 13. -№4. -P. 904-918.

527. Ulrik C.S. Prognosis and risk factors for bronchial asthma/ZDanish Medical Bulletin. -1998. -Vol. 45. -№5. -P. 480-494.

528. Urban R.C. Jr., Cotlier E. Corticosteroid-induced cataractsZZSurv. Ophthalmol. -1986.-Vol. 31.-P. 102-110.

529. Vachier I., Chiappara G., Vignola A.M. et al. Glucocorticoid receptors in bronchial epithelial cells in asthmaZZAm. J. Respir. Crit. Care Med. -1998 Sep. -Vol. 158. -№3. -P. 963-970.

530. Van-Aalderen W.M., Sprikkelman A.B., Hoekstra M.O. Is childhood asthma an inflammatory disease?ZZAllergy. -1999. -Vol. 54. -Suppl. 49. -P. 62-67.

531. Van-der-Molen Т., Meyboom-de-Jong В., Mulder H.H. et al. Starting with a higher dose of inhaled corticosteroids in primary care asthma treatment//Am. J. Respir. Crit. Care Med. -1998 Jul. -Vol. 158. -№1. -P. 121-125.

532. Van-der-Velden V.H. Glucocorticoids: mechanisms od action and antiinflammatory potential in asthma//Mediators Inflamm. -1998. -Vol. 7. -№4. -P. 229-237.

533. Van-Ganse E., Hubloue I., Vincken W. et al. Actual use of inhaled corticosteroids and risk of hospitalization: a case-control study//Eur. J. Clin. Pharmacol. -1997. -Vol. 51. -№6. -P. 449-454.

534. Van-Ganse E., van-der-Linden P.D., Leufkens H.G. et al. Asthma medications and disease exacerbations: an epidemiological study as a method for asthma surveillance//Eur. Respir. J. -1995 Nov. -Vol. 8. -№11. -P. 1856-1860.

535. Van-Grunsven P.M., Van-Schayck C.P., Molema J. et al. Effect of inhaled corticosteroids on bronchial responsiveness in patients with "corticosteroid naive" mild asthma: a meta-analysis//Thorax. -1999 Apt. -Vol. 54. -№4. -P. 316-322.

536. Van-Hal P.T., Overbeek S.E., Hoogstenden H.C. et al. Eicosanoids and lipocortin-1 in BAL fluid in asthma; effects of smoking and inhaled glucocorticoids//! Appl. Physiol. -1996 Aug. -Vol. 81. -№2. -P. 548-555.

537. Vatheneh A.S., Knox A.J., Wisniewski A et al. Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma//Ibid. -1991. -Vol. 143. -P. 1317-1321.

538. Vav-renses E.L., Straathof K.C., Veselic-Charvat M.F. et al. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils and exhaled nitric oxide levels in patients with asthma//Thorax. -1999 May. -Vol. 54. -№50. -P. 403-408.

539. Verberne A.A., Frost C., Roorda R.J. et al. One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group//Am. J. Respir. Crit. Care Med. -1997 Sep. -Vol. 156. -№3 (Ptl). -P. 688-695.

540. Verheggen M.M., Adriaansen-Soeting P.W., Berrevoets C.A. et al. Glucocorticoid receptor expression in human bronchial epithelial cells: effects of smoking and COPD//Mediators-Inflamm. -1998. -Vol. 7. -№4. -P. 275-281.

541. Viksman M.Y., Liu M.C., Bickel C.A. et al. Phenotypic analysis of alveolar macrophages and monocytes in allergic airway inflammation//Am. J. Respir. Crit. Care Med. -1997. -Vol. 155. -P. 858-863.

542. Vrugt В., Djukanovic R., Bron R. et al. New insights into the pathogenesis of severe corticosteroid-dependent asthma//! Allergy Clin. Immunol. -1996 Nov. -Vol. 98. -№5 (Pt2). -P. 22-26.

543. Vrugt В., Wilson S., Underwood J. et al. Mucosal inflammation in severe glucocorticoid-dependent asthma//Eur. Respir. J. -1999 Jun. -Vol. 13. -№6. -P. 1245-1252.

544. Walker С., Kaegi M.K., Braiin P. et al. Activated T-cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity//! Allergy Clin. Immunol. -1991. -Vol. 88. -P. 935-942.

545. Ward J.K., Belvisi M.G., Fox A.J. et al. Modulation of cholinergic neural bronchoconstriction by endogenous nitric oxide and vasoactive intestinal peptide in human airways in vitro//J. Clin. Invest. -1993. -Vol. 92. -P. 736-743.

546. Wardlaw A.J., Dunette S., Gleich G.J. et al. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma//Am. Rev. Respir. Dis. -1988. -Vol. 137. -P. 62-69.

547. Wardlaw A.J., Dunnette S., Gleich G.J. et al. Eosinophils and mast cells in bronchoalveolar lavage in subjects with asthma and subjects with chronic airflow inflammation//Am. Rev. Respir. Dis. -1992. -Vol. 145. -P. 922-927.

548. Warner J.O. Asthma: A follow up statement from an international paediatric asthma consensus group//Arch. Dis. Child. -1992. -Vol. 67. -P. 240-248.

549. Watanabe K., Senju S., Toyoshima H. et al. Thickness of the basement membrane of bronchial epithelial cells in lung diseases as determined by transbronchial biopsy/ZRespir. Med. -1997 Aug. -Vol. 91. -№7. -P. 406-410.

550. Watkins N., Knight D., Garlepp M. et al. Inducible nitric oxide synthase mRNA in human airway epithelium//Eur. Resp. J. -1995. .-Vol. 8. -S. 19. -P. 41.

551. Welch M.J. Inhaled steroids and severe viral infections//J. Asthma. -1994. -Vol. 31.-P. 43-50.

552. Wennergren G., Nordvall S.L., Hedlin G. Nebulized budesonide for the treatment of moderate to severe asthma in infants and toddlers//Acta-Paediatr. -1996 Feb. -Vol. 85. -№2. -P. 183-189.

553. Wenzel S.E., Szefler S.J., Leung D.Y. et al. Bronchoscope evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids//Am. J. Respir. Crit. Care Med. -1997 Sep. -Vol. 156. -№3 (Ptl). -P. 737-743.

554. Wever A.M., Wever-Hess J., Hermans J. The use of serum eosinophil cationic protein (ECP) in the management of steroid therapy in chronic asthma//Clin. Exp. Allergy. -1997 May. -Vol. 27. -№5. -P. 519-529.

555. Wilson J.W., Li X. The measurement of reticular basement membrane and submucosal collagen in the asthmatic airway//Clin. Exp. Allergy. -1997 Apr. -Vol. 27. -№4. -P. 363-371.

556. Wilson N.M., Silverman M. Treatment of acute, episodic asthma in pre-school children using intermittent high dose inhaled steroids at home//Arch. Dis. Child. -1990. -Vol. 65. -P. 407-410.

557. Wisniewski A., Lewis S., Maslanka W.B. et al. A cross-sectional study of the effects of inhaled steroids on bone density & bone metabolism in patients with asthma//Am. J. Respir. Crit. Care Med. -1995. -Vol. 151. -P. 374.

558. Wolthers O.D. Long, -intermediate, -and short-term growth studies in asthmatic children treated with inhaled glucocorticosteroids//Eur. Respir. J. -1996. -Vol. 9. -№4. -P. 821-827.

559. Wolthers O.D., Juul A., Hansen M. et al. The insulin-like growth factor axis and collagen turnover in asthmatic children treated with inhaled budesonide//Acta Paediatr. -1995. -Vol. 84. -P. 393-397.

560. Wolthers O.D., Heuck C. Differential effects of inhaled budesonide on serum osteocalcin in children and adolescents with asthma/ZPediatr. Allergy Immunol. -1998 Aug. -Vol. 9. -№3. -P. 150-155.

561. Wolthers O.D., Pedersen S. Growth of asthmatic children during treatment with budesonide: A double blind trial//Ibid. -1991. -Vol. 303. -№6795. -P. 163-165.

562. Wolthers O.D., Pedersen S. Linear growth in asthmatic schoolchildren treated with inhaled budesonide//Eur. Respir. J. -1992. -Vol. 5. -Suppl. 5. -P. 1004-1006.

563. Woolley K.I., Adelroth E., Woolley M.J. et al. Granulocyte-macrophage colony-stimulating factor, eosinophils and eosinophils cationic protein in subjects with and without mild, stable, atopic asthma//Eur. Respir. J. -1994. -Vol. 7. -P. 1576-1584.

564. Wurthwein G, Rohdewald P. Activation of beclomethasone dipropionate by hydrolysis to beclomethasone-17-monopropionate//Biopharm. Drug Dispos. -1990. -Vol. 11.-P. 381-394.

565. Xiang X., Zhou H., Yao W. Effects of inhalated isosorbide dinitrate on endothelin and nitric oxide and its therapeutic efficacy for experimental guinea-pigs with asthma/ZHunan I Ко Та Hsueh Hsueh Pao. -1997. -Vol. 22. -№3. -P. 220-222.

566. Yates D.H., Kharitonov S.A., Robbins R.A. et al. Effect of a nitric oxide synthase inhibitor and glucocortocosteroids on exhaled nitric oxideZZAm. J. Respir. Crit. Care Med. -1995. -Vol. 152. -P. 892-896.

567. Yavuz O., Turktas I., Cevik C. The effect of high-dose inhaled budesonide on lipid profile ib asthmatic patientsZZGen. Pharmacol. -1996 Jan. -Vol. 27. -№1. -P. 89-90.

568. Yokoyama A., Kohno N., Hamada H. et al. Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis//Am. J. Respir. Crit. Care Med. -1998 Nov. -Vol. 158. -№5 (Ptl). -P. 1680-1684.

569. Yokoyama A., Kohno N., Kondo K. et al. Comparative evaluation of sialylated carbohydrate antigens, KL-6, CA19-9 and SLX as serum markers for interstitial pneumonia/ZRespirology. -1998 Sep. -Vol. 3. -№3. -P. 199-202.

570. Yu G., Bjorksten B. Polyunsaturated fatty acids in school children in relation to allergy and serum IgE levels/ZPediatr. Allergy Immunol. -1998 Aug. -Vol. 9. -№3. -P. 133138.

571. Zaitsu M., Hamasaki Y., Ishii K. et al. Direct evidence that LTC4 and LTB4 but not TXA2 are involved in asthma attacks in children//! Asthma. -1998. -Vol. 35. -№5. -P. 445-448.

572. Zhang H., Yang Y., Weng X. A preliminary observation on the effects of inhaled nitric oxide on bronchial asthma//Chung Hua Nei Ко Tsa Chih. -1995 Dec. -Vol. 34. -№12. -P. 805-807.

573. ZuWallack R.L., Rosen J.P., Cohen L. et al. The effectiveness of once-daily dosing of inhaled flunisolide in maintaining asthma control//! Allergy Clin. Immunol. -1997 Mar. -Vol. 99. -№3. -P. 278-285.О